C3.ai (AI) 10-Q 7 Dec 22 2023 Q2 Quarterly report Financial data

Cover

Cover - shares	6 Months Ended
	Oct. 31, 2022	Dec. 02, 2022
Document Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Oct. 31, 2022
Document Transition Report	false
Entity File Number	001-39744
Entity Registrant Name	C3.ai, Inc.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	26-3999357
Entity Address, Address Line One	1300 Seaport Blvd,
Entity Address, Address Line Two	Suite 500
Entity Address, City or Town	Redwood City,
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	94063
City Area Code	650
Local Phone Number	503-2200
Title of 12(b) Security	Class A Common Stock, par value $0.001 per share
Trading Symbol	AI
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Current Fiscal Year End Date	--04-30
Amendment Flag	false
Entity Central Index Key	0001577526
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q2
Class A Common Stock
Document Information [Line Items]
Entity Common Stock, Shares Outstanding (in shares)		106,751,070
Class B Common Stock
Document Information [Line Items]
Entity Common Stock, Shares Outstanding (in shares)		3,499,992

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands		Oct. 31, 2022	Apr. 30, 2022
Current assets
Cash and cash equivalents		$ 277,622	$ 339,528
Short-term investments		562,448	620,633
Accounts receivable, net of allowance of $337 and $157 as of October 31, 2022 and April 30, 2022, respectively	[1]	94,759	80,271
Prepaid expenses and other current assets	[2]	25,239	20,004
Total current assets		960,068	1,060,436
Property and equipment, net		61,724	14,517
Goodwill		625	625
Long-term investments		18,686	32,086
Other assets, non-current	[3]	59,502	63,218
Total assets		1,100,605	1,170,882
Current liabilities
Accounts payable	[4]	30,662	54,218
Accrued compensation and employee benefits		37,728	32,223
Deferred revenue, current	[5]	30,380	48,854
Accrued and other current liabilities	[6]	19,885	14,874
Total current liabilities		118,655	150,169
Deferred revenue, non-current		228	288
Other long-term liabilities	[7]	28,556	30,948
Total liabilities		147,439	181,405
Commitments and contingencies (note 6)
Stockholders’ equity
Additional paid-in capital		1,637,980	1,532,917
Accumulated other comprehensive loss		(2,805)	(2,148)
Accumulated deficit		(682,119)	(541,398)
Total stockholders’ equity		953,166	989,477
Total liabilities and stockholders’ equity		1,100,605	1,170,882
Class A Common Stock
Stockholders’ equity
Common stock		107	103
Class B Common Stock
Stockholders’ equity
Common stock		$ 3	$ 3
[1]Including amounts from a related party of $53,871 and $35,848 as of October 31, 2022 and April 30, 2022, respectively.[2]Including amounts from a related party of $4,862 and $4,862 as of October 31, 2022 and April 30, 2022, respectively.[3]Including amounts from a related party of $13,710 and $16,141 as of October 31, 2022 and April 30, 2022, respectively.[4]Including amounts from a related party of $2,153 and $18,549 as of October 31, 2022 and April 30, 2022, respectively.[5]Including amounts from a related party of $387 and $132 as of October 31, 2022 and April 30, 2022, respectively.[6]Including amounts from a related party of $2,448 and $2,510 as of October 31, 2022 and April 30, 2022, respectively.[7]Including amounts from a related party of nil and $2,448 as of October 31, 2022 and April 30, 2022, respectively.

CONDENSED CONSOLIDATED BALANC_2

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Thousands		Oct. 31, 2022	Apr. 30, 2022
Accounts receivable, allowance		$ 337	$ 157
Accounts receivable, net, from related party		53,871	35,848
Prepaid expenses and other current assets, from related party	[1]	25,239	20,004
Other assets, non-current, due from related party	[2]	59,502	63,218
Accounts payable, from related party		2,153	18,549
Deferred revenue, current, from related party	[3]	30,380	48,854
Accrued and other current liabilities, from related party	[4]	19,885	14,874
Other long-term liabilities, from related party		0	2,448
Related Party
Prepaid expenses and other current assets, from related party		4,862	4,862
Other assets, non-current, due from related party		13,710	16,141
Deferred revenue, current, from related party		387	132
Accrued and other current liabilities, from related party		$ 2,448	$ 2,510
Class A Common Stock
Common stock, par value (in dollars per share)		$ 0.001	$ 0.001
Common stock, shares authorized (in shares)		1,000,000,000	1,000,000,000
Common stock, shares issued (in shares)		106,600,493	102,725,041
Common stock, shares outstanding (in shares)		106,600,493	102,725,041
Class B Common Stock
Common stock, par value (in dollars per share)		$ 0.001	$ 0.001
Common stock, shares authorized (in shares)		3,500,000	3,500,000
Common stock, shares issued (in shares)		3,499,992	3,499,992
Common stock, shares outstanding (in shares)		3,499,992	3,499,992
[1]Including amounts from a related party of $4,862 and $4,862 as of October 31, 2022 and April 30, 2022, respectively.[2]Including amounts from a related party of $13,710 and $16,141 as of October 31, 2022 and April 30, 2022, respectively.[3]Including amounts from a related party of $387 and $132 as of October 31, 2022 and April 30, 2022, respectively.[4]Including amounts from a related party of $2,448 and $2,510 as of October 31, 2022 and April 30, 2022, respectively.

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands		3 Months Ended		6 Months Ended
		Oct. 31, 2022	Oct. 31, 2021	Oct. 31, 2022	Oct. 31, 2021
Revenue
Total revenue		$ 62,408	$ 58,263	$ 127,716	$ 110,669
Cost of revenue
Total cost of revenue		20,752	15,971	39,158	28,996
Gross profit		41,656	42,292	88,558	81,673
Operating expenses
Sales and marketing	[1]	44,936	46,166	87,923	82,988
Research and development		50,051	36,523	105,928	63,235
General and administrative		18,635	15,279	39,882	27,643
Total operating expenses		113,622	97,968	233,733	173,866
Loss from operations		(71,966)	(55,676)	(145,175)	(92,193)
Interest income		4,224	322	6,762	667
Other (expense) income, net		(945)	(1,372)	(1,966)	(2,271)
Loss before provision for income taxes		(68,687)	(56,726)	(140,379)	(93,797)
Provision for income taxes		163	13	342	401
Net loss		$ (68,850)	$ (56,739)	$ (140,721)	$ (94,198)
Net loss per share attributable to Class A and Class B common stockholders, basic (in dollars per share)		$ (0.63)	$ (0.55)	$ (1.30)	$ (0.91)
Net loss per share attributable to Class A and Class B common stockholders, diluted (in dollars per share)		$ (0.63)	$ (0.55)	$ (1.30)	$ (0.91)
Weighted-average shares used in computing net loss per share attributable to Class A and Class B common stockholders, basic (in shares)		108,876	103,746	107,885	103,058
Weighted-average shares used in computing net loss per share attributable to Class A and Class B common stockholders, diluted (in shares)		108,876	103,746	107,885	103,058
Subscription
Revenue
Total revenue	[2]	$ 59,508	$ 47,408	$ 116,534	$ 93,530
Cost of revenue
Total cost of revenue	[3]	19,165	11,392	33,257	20,605
Professional services
Revenue
Total revenue	[4]	2,900	10,855	11,182	17,139
Cost of revenue
Total cost of revenue		$ 1,587	$ 4,579	$ 5,901	$ 8,391
[1]Including related party sales and marketing expense of $3,531 and $131 for the three months ended October 31, 2022 and 2021, respectively, and $7,031 and $192 for the six months ended October 31, 2022 and 2021, respectively.[2]Including related party revenue of $19,238 and $10,012 for the three months ended October 31, 2022 and 2021, respectively, and $35,568 and $20,220 for the six months ended October 31, 2022 and 2021, respectively.[3]Including related party cost of revenue of nil and $80 for the three months ended October 31, 2022 and 2021, respectively, and nil and $197 for the six months ended October 31, 2022 and 2021, respectively.[4]Including related party revenue of $21 and $5,924 for the three months ended October 31, 2022 and 2021, respectively, and $150 and $7,998 for the six months ended October 31, 2022 and 2021, respectively.

CONDENSED CONSOLIDATED STATEM_2

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Parenthetical) - USD ($) $ in Thousands		3 Months Ended		6 Months Ended
		Oct. 31, 2022	Oct. 31, 2021	Oct. 31, 2022	Oct. 31, 2021
Related party cost of revenue		$ 20,752	$ 15,971	$ 39,158	$ 28,996
Related party sales and marketing	[1]	44,936	46,166	87,923	82,988
Investor
Related party sales and marketing		3,531	131	7,031	192
Subscription
Related party cost of revenue	[2]	19,165	11,392	33,257	20,605
Subscription | Investor
Related party revenue		19,238	10,012	35,568	20,220
Related party cost of revenue		0	80	0	197
Professional services
Related party cost of revenue		1,587	4,579	5,901	8,391
Professional services | Investor
Related party revenue		$ 21	$ 5,924	$ 150	$ 7,998
[1]Including related party sales and marketing expense of $3,531 and $131 for the three months ended October 31, 2022 and 2021, respectively, and $7,031 and $192 for the six months ended October 31, 2022 and 2021, respectively.[2]Including related party cost of revenue of nil and $80 for the three months ended October 31, 2022 and 2021, respectively, and nil and $197 for the six months ended October 31, 2022 and 2021, respectively.

CONDENSED CONSOLIDATED STATEM_3

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Oct. 31, 2022	Oct. 31, 2021	Oct. 31, 2022	Oct. 31, 2021
Statement of Comprehensive Income [Abstract]
Net loss	$ (68,850)	$ (56,739)	$ (140,721)	$ (94,198)
Other comprehensive loss
Unrealized loss on available-for-sale marketable securities, net of tax	(457)	(427)	(657)	(321)
Comprehensive loss	$ (69,307)	$ (57,166)	$ (141,378)	$ (94,519)

CONDENSED CONSOLIDATED STATEM_4

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) shares in Thousands, $ in Thousands	Total	RSUs	Common Stock	Common Stock RSUs	Additional Paid-In Capital	Additional Paid-In Capital RSUs	Accumulated Other Comprehensive Loss	Accumulated Deficit
Beginning Balance, shares (in shares) at Apr. 30, 2021			102,167
Beginning Balance, Amount at Apr. 30, 2021	$ 1,061,175		$ 102		$ 1,410,325		$ 81	$ (349,333)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of Class A common stock upon exercise of stock options, net of repurchases (in shares)			2,667
Issuance of Class A common stock upon exercise of stock options, net of repurchases	11,494		$ 3		11,491
Vesting of early exercised Class A common stock options	1,908				1,908
Vesting of restricted stock units (in shares)				37
Stock-based compensation expense	46,452				46,452
Other comprehensive loss	(321)						(321)
Net loss	(94,198)							(94,198)
Ending Balance, shares (in shares) at Oct. 31, 2021			104,871
Ending Balance, Amount at Oct. 31, 2021	1,026,510		$ 105		1,470,176		(240)	(443,531)
Beginning Balance, shares (in shares) at Jul. 31, 2021			103,868
Beginning Balance, Amount at Jul. 31, 2021	1,043,795		$ 104		1,430,296		187	(386,792)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of Class A common stock upon exercise of stock options, net of repurchases (in shares)			974
Issuance of Class A common stock upon exercise of stock options, net of repurchases	6,492		$ 1		6,491
Vesting of early exercised Class A common stock options	849				849
Vesting of restricted stock units (in shares)				29
Stock-based compensation expense	32,540				32,540
Other comprehensive loss	(427)						(427)
Net loss	(56,739)							(56,739)
Ending Balance, shares (in shares) at Oct. 31, 2021			104,871
Ending Balance, Amount at Oct. 31, 2021	1,026,510		$ 105		1,470,176		(240)	(443,531)
Beginning Balance, shares (in shares) at Apr. 30, 2022			106,225
Beginning Balance, Amount at Apr. 30, 2022	$ 989,477		$ 106		1,532,917		(2,148)	(541,398)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of Class A common stock upon exercise of stock options, net of repurchases (in shares)	577		568
Issuance of Class A common stock upon exercise of stock options, net of repurchases	$ 1,800		$ 1		1,799
Vesting of early exercised Class A common stock options	551				551
Tax withholding related to net share settlement of equity awards (in shares)			(221)
Tax withholding related to net share settlement of equity awards	(3,375)				(3,375)
Vesting of restricted stock units (in shares)				3,529
Vesting of restricted stock units		$ 13,672		$ 3		$ 13,669
Stock-based compensation expense	92,419				92,419
Other comprehensive loss	(657)						(657)
Net loss	(140,721)							(140,721)
Ending Balance, shares (in shares) at Oct. 31, 2022			110,101
Ending Balance, Amount at Oct. 31, 2022	953,166		$ 110		1,637,980		(2,805)	(682,119)
Beginning Balance, shares (in shares) at Jul. 31, 2022			108,344
Beginning Balance, Amount at Jul. 31, 2022	978,978		$ 108		1,594,487		(2,348)	(613,269)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of Class A common stock upon exercise of stock options, net of repurchases (in shares)			289
Issuance of Class A common stock upon exercise of stock options, net of repurchases	697		$ 0		697
Vesting of early exercised Class A common stock options	219				219
Tax withholding related to net share settlement of equity awards (in shares)			(221)
Tax withholding related to net share settlement of equity awards	(3,375)				(3,375)
Vesting of restricted stock units (in shares)				1,689
Vesting of restricted stock units		$ 2		$ 2
Stock-based compensation expense	45,952				45,952
Other comprehensive loss	(457)						(457)
Net loss	(68,850)							(68,850)
Ending Balance, shares (in shares) at Oct. 31, 2022			110,101
Ending Balance, Amount at Oct. 31, 2022	$ 953,166		$ 110		$ 1,637,980		$ (2,805)	$ (682,119)

CONDENSED CONSOLIDATED STATEM_5

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands		6 Months Ended
		Oct. 31, 2022	Oct. 31, 2021
Cash flows from operating activities:
Net loss		$ (140,721)	$ (94,198)
Adjustments to reconcile net loss to net cash used in operating activities
Depreciation and amortization		2,413	2,364
Non-cash operating lease cost		1,101	1,100
Stock-based compensation expense		112,643	46,452
Other		(396)	(538)
Changes in operating assets and liabilities
Accounts receivable	[1]	(14,668)	39,047
Prepaid expenses, other current assets and other assets	[2]	(3,204)	(15,074)
Accounts payable	[3]	(28,197)	(1,682)
Accrued compensation and employee benefits		(1,050)	(5,351)
Operating lease liabilities		650	(1,214)
Other liabilities	[4]	(882)	13,564
Deferred revenue	[5]	(18,534)	(2,346)
Net cash used in operating activities		(90,845)	(17,876)
Cash flows from investing activities:
Purchases of property and equipment		(39,978)	(1,429)
Capitalized software development costs		(1,000)	(500)
Purchases of investments		(384,024)	(388,870)
Maturities and sales of investments		455,534	461,648
Net cash provided by investing activities		30,532	70,849
Cash flows from financing activities:
Payment of deferred offering costs		0	(105)
Proceeds from exercise of Class A common stock options		1,782	11,305
Taxes paid related to net share settlement of equity awards		(3,375)	0
Net cash (used in) provided by financing activities		(1,593)	11,200
Net (decrease) increase in cash, cash equivalents and restricted cash		(61,906)	64,173
Cash, cash equivalents and restricted cash at beginning of period		352,519	116,255
Cash and cash equivalents		277,622	167,436
Restricted cash included in other assets, non-current		12,566	12,567
Restricted cash included in prepaid expenses and other current assets		425	425
Cash, cash equivalents and restricted cash at end of period		290,613	180,428
Total cash, cash equivalents and restricted cash		290,613	180,428
Supplemental disclosure of cash flow information—cash paid for income taxes		136	625
Supplemental disclosures of non-cash investing and financing activities:
Purchases of property and equipment included in accounts payable and accrued liabilities		18,361	52
Unpaid liabilities related to intangible purchases		1,500	2,500
Vesting of early exercised stock options		$ 561	$ 1,908
[1]Including changes in related party balances of $18,023 and $(5,796) for the six months ended October 31, 2022 and 2021, respectively.[2]Including changes in related party balances of $(2,431) and $15,323 for the six months ended October 31, 2022 and 2021, respectively.[3]Including changes in related party balances of $(16,396) and $28 for the six months ended October 31, 2022 and 2021, respectively.[4]Including changes in related party balances of $(2,510) and $12,598 for the six months ended October 31, 2022 and 2021, respectively.[5]Including changes in related party balances of $255 and $9,819 for the six months ended October 31, 2022 and 2021, respectively.

CONDENSED CONSOLIDATED STATEM_6

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical) - USD ($) $ in Thousands		6 Months Ended
		Oct. 31, 2022	Oct. 31, 2021
Related party balanced included in prepaid expenses, other current assets and other assets	[1]	$ 3,204	$ 15,074
Related party balances included in other liabilities	[2]	(882)	13,564
Investor
Related party balances included in accounts receivable		18,023	(5,796)
Related party balanced included in prepaid expenses, other current assets and other assets		(2,431)	15,323
Related party balances included in accounts payable		(16,396)	28
Related party balances included in other liabilities		(2,510)	12,598
Related party balance included in deferred revenue		$ 255	$ 9,819
[1]Including changes in related party balances of $(2,431) and $15,323 for the six months ended October 31, 2022 and 2021, respectively.[2]Including changes in related party balances of $(2,510) and $12,598 for the six months ended October 31, 2022 and 2021, respectively.

Summary of Business and Signifi

Summary of Business and Significant Accounting Policies	6 Months Ended
	Oct. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Summary of Business and Significant Accounting Policies	Summary of Business and Significant Accounting Policies Business C3.ai, Inc. (including its subsidiaries, “C3 AI” or “the Company”) is an enterprise artificial intelligence (“AI”) software provider. The Company’s C3 AI Platform supports accelerating digital transformation in various industries with prebuilt and configurable C3 AI Applications for business use cases including predictive maintenance, fraud detection, sensor network health, supply network optimization, energy management, anti-money laundering, and customer engagement. The Company supports customers in the United States, Europe, and the rest of the world. The Company was initially formed as a limited liability company in Delaware on January 8, 2009 and converted to a Delaware corporation in June 2012. Basis of Presentation and Principles of Consolidation The Company prepares its unaudited condensed consolidated financial statements in accordance with generally accepted accounting principles in the United States (“U.S. GAAP”) and applicable rules and regulations of the U.S. Securities and Exchange Commission (the “SEC”) regarding interim financial reporting. Accordingly, they do not include all disclosures normally required in annual consolidated financial statements prepared in accordance with U.S. GAAP. Therefore, these unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes included in the Company’s Annual Report on Form 10-K for the fiscal year ended April 30, 2022, which was filed with the SEC on June 23, 2022. In management’s opinion, these unaudited condensed consolidated financial statements have been prepared on the same basis as the annual financial statements and reflect all adjustments, which include only normal recurring adjustments necessary for the fair statement of the Company’s financial position as of October 31, 2022 and the results of operations for the three and six months ended October 31, 2022. The results of operations for the three and six months ended October 31, 2022 are not necessarily indicative of the results to be expected for the full year or any other future interim or annual period. The condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation. Use of Estimates The preparation of the accompanying unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions about future events. These estimates and the underlying assumptions affect the amounts of assets and liabilities reported, disclosures about contingent assets and liabilities, and reported amounts of revenue and expenses. Actual results and outcomes could differ significantly from the Company’s estimates, judgments, and assumptions. Significant estimates include, but are not limited to, determining standalone selling price for performance obligations in contracts with customers and estimating variable consideration, the estimated expected benefit period for deferred contract acquisition costs, the useful lives of long-lived assets, the incremental borrowing rate for operating leases and other assumptions used to measure stock-based compensation, and the valuation of deferred income tax assets and uncertain tax positions. These estimates and assumptions are based on management’s best estimates and judgment. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, which management believes to be reasonable under the circumstances. The Company adjusts such estimates and assumptions when facts and circumstances dictate. Changes in those estimates resulting from continuing changes in the economic environment will be reflected in the financial statements in future periods. As future events and their effects cannot be determined with precision, actual results could materially differ from those estimates and assumptions. Fiscal Year The Company’s fiscal year ends on April 30. Summary of Significant Accounting Policies The Company’s significant accounting policies are discussed in Note 1. Summary of Business and Significant Accounting Policies in the Notes to Consolidated Financial Statements in its Annual Report on Form 10-K for the fiscal year ended April 30, 2022, which was filed with the SEC on June 23, 2022. There have been no significant changes to these policies during the three and six months ended October 31, 2022.

Revenue

Revenue	6 Months Ended
	Oct. 31, 2022
Revenue from Contract with Customer [Abstract]
Revenue	Revenue Disaggregation of Revenue The following table presents revenue by geographical region (in thousands): Three Months Ended October 31, Six Months Ended October 31, 2022 2021 2022 2021 North America (1) $ 47,916 $ 43,697 $ 99,854 $ 80,149 Europe, the Middle East and Africa (1) 11,889 12,789 22,592 25,008 Asia Pacific (1) 2,435 1,777 4,802 5,512 Rest of World (1) 168 — 468 — Total revenue $ 62,408 $ 58,263 $ 127,716 $ 110,669 __________________ (1) The United States comprised 77% and 75% of the Company’s revenue for the three months ended October 31, 2022 and 2021, respectively, and 78% and 72% of the Company’s revenue for the six months ended October 31, 2022 and 2021, respectively. France comprised 12% of the Company’s revenue for the three months ended October 31, 2021, and 12% of the Company’s revenue for the six months ended October 31, 2021. No other country comprised 10% or greater of the Company’s revenue for the three and six months ended October 31, 2022 or 2021. Deferred Revenue As of October 31, 2022 and April 30, 2022, the Company's deferred revenue balances were $30.6 million and $49.1 million, respectively. Revenue of $39.5 million and $56.9 million was recognized during the six months ended October 31, 2022 and 2021, respectively, that was included in the deferred revenue balances as of April 30, 2022 and 2021, respectively. Remaining Performance Obligation Remaining performance obligations are committed and represent non-cancellable contracted revenue that has not yet been recognized and will be recognized as revenue in future periods. Some contracts allow customers to cancel the contracts without a significant penalty, and the cancellable amount of contract value is not included in the remaining performance obligations. The Company excludes amounts related to performance obligations and usage-based royalties that are billed and recognized as they are delivered or billed and recognized in the same period. This primarily consists of monthly usage-based runtime and hosting charges in the duration of some revenue contracts. Revenue expected to be recognized from remaining performance obligations was approximately $417.3 million as of October 31, 2022, of which $164.5 million is expected to be recognized over the next 12 months and the remainder thereafter. Customer Concentration and Accounts Receivable All of the Company’s Customer-Entities consist of corporate and governmental entities. A limited number of Customer-Entities have accounted for a large part of the Company’s revenue and accounts receivable to date. For the purpose of determining customer concentration and accounts receivable, unbilled receivables have been excluded from accounts receivable balance. One Customer-Entity accounted for 32% of revenue for the three months ended October 31, 2022. Two separate Customer-Entities accounted for 28% and 11%, respectively, of revenue for the three months ended October 31, 2021. One Customer-Entity accounted for 29% of revenue for the six months ended October 31, 2022. Two separate Customer-Entities accounted for 25% and 12%, respectively, of revenue for the six months ended October 31, 2021. Two separate Customer-Entities accounted for 26% and 11%, respectively, of accounts receivable at October 31, 2022. Three separate Customer-Entities accounted for 32%, 13% and 12%, respectively, of accounts receivable at April 30, 2022. A Customer-Entity is defined as each entity that is the ultimate parent of a party contracting with the Company.

Fair Value Measurements

Fair Value Measurements	6 Months Ended
	Oct. 31, 2022
Fair Value Disclosures [Abstract]
Fair Value Measurements	Fair Value Measurements The Company’s financial instruments consist primarily of cash equivalents, restricted cash, available-for-sale marketable securities, accounts receivable, and accounts payable. Cash equivalents and available-for-sale marketable securities are reported at their respective fair values on the condensed consolidated balance sheets. The remaining financial instruments are reported on the condensed consolidated balance sheets at amounts that approximate current fair values. The following table summarizes the types of assets measured at fair value on a recurring basis by level within the fair value hierarchy (in thousands): As of October 31, 2022 As of April 30, 2022 Level 1 Level 2 Level 3 Total Level 1 Level 2 Level 3 Total Cash equivalents: Money market funds $ 160,068 $ — $ — $ 160,068 $ 107,726 $ — $ — $ 107,726 Certificates of deposit — — — — — 3,000 — 3,000 Commercial paper 79,664 — 79,664 — 142,511 — 142,511 Corporate debt securities — — — — — 8,884 — 8,884 Available-for-sale marketable securities: U.S. treasury securities 12,326 — 12,326 — 12,763 — 12,763 Certificates of deposit — 90,481 — 90,481 — 97,205 — 97,205 U.S. government agencies securities — 23,836 — 23,836 — 13,890 — 13,890 Commercial paper — 184,185 — 184,185 — 241,132 — 241,132 Corporate debt securities — 270,306 — 270,306 — 287,729 — 287,729 Total cash equivalents and available-for-sale marketable securities $ 160,068 $ 660,798 $ — $ 820,866 $ 107,726 $ 807,114 $ — $ 914,840 The estimated fair value of securities classified as Level 2 financial instruments was determined based on third-party pricing services. The pricing services utilize industry standard valuation models, including both income- and market-based approaches, for which all significant inputs are observable, either directly or indirectly, to estimate fair value. Inputs used for fair value measurement categorized as Level 2 include benchmark yields, reported trades, broker or dealer quotes, issuer spreads, two-sided markets, benchmark securities, bids, offers, and reference data including market research publications.

Investments

Investments	6 Months Ended
	Oct. 31, 2022
Investments, Debt and Equity Securities [Abstract]
Investments	Investments Cash Equivalents and Available-for-Sale Marketable Securities The following table summarizes the Company’s cash equivalents and available-for-sale marketable securities (in thousands): As of October 31, 2022 As of April 30, 2022 Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Estimated Fair Value Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Estimated Fair Value Cash equivalents: Money market funds $ 160,068 $ — $ — $ 160,068 $ 107,726 $ — $ — $ 107,726 Certificates of deposit — — 3,000 — — 3,000 Commercial paper 79,664 — — 79,664 142,511 — — 142,511 Corporate debt securities — — — — 8,889 — (5) 8,884 Available-for-sale marketable securities: U.S. treasury securities 12,381 1 (56) 12,326 12,764 — (1) 12,763 Certificates of deposit 90,481 — — 90,481 97,205 — — 97,205 U.S. government agencies securities 24,217 — (381) 23,836 14,113 — (223) 13,890 Commercial paper 184,185 — — 184,185 241,134 — (2) 241,132 Corporate debt securities 272,675 3 (2,372) 270,306 289,646 20 (1,937) 287,729 Total cash equivalents and available-for-sale marketable securities $ 823,671 $ 4 $ (2,809) $ 820,866 $ 916,988 $ 20 $ (2,168) $ 914,840 The following table summarizes the Company’s available-for-sale marketable securities by contractual maturity (in thousands): As of October 31, 2022 As of April 30, 2022 Amortized Cost Fair Value Amortized Cost Fair Value Within one year $ 565,153 $ 562,448 $ 622,517 $ 620,633 After one year through five years 18,784 18,686 32,345 32,086 Total $ 583,937 $ 581,134 $ 654,862 $ 652,719 The following table summarizes the fair values and unrealized losses of the Company’s available-for-sale marketable securities classified by length of time that the securities have been in a continuous unrealized loss position but were not deemed to be other-than-temporarily impaired, as of October 31, 2022 (in thousands): As of October 31, 2022 Less Than 12 Months 12 Months or Greater Total Unrealized Losses Fair Value Unrealized Losses Fair Value Unrealized Losses Fair Value U.S. treasury securities $ (56) $ 12,325 $ — $ — $ (56) $ 12,325 U.S. government agencies securities (381) 23,836 — — (381) 23,836 Commercial paper — 3,022 — — — 3,022 Corporate debt securities (2,270) 247,254 (102) 10,503 (2,372) 257,757 Total $ (2,707) $ 286,437 $ (102) $ 10,503 $ (2,809) $ 296,940

Balance Sheet Details

Balance Sheet Details	6 Months Ended
	Oct. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Balance Sheet Details	Balance Sheet Details Property and Equipment, Net Property and equipment consisted of the following at October 31, 2022 and April 30, 2022 (in thousands): Useful Life As of October 31, As of April 30, (in months) 2022 2022 Leasehold improvements * $ 8,878 $ 8,878 Computer equipment 36 4,304 3,321 Office furniture and equipment 60 381 348 Capital in progress NA 59,320 11,261 Property and equipment—gross 72,883 23,808 Less: accumulated depreciation and amortization (11,159) (9,291) Property and equipment—net $ 61,724 $ 14,517 __________________ * Leasehold improvements are amortized over the shorter of the estimated useful lives of the improvements or the remaining lease term. NA = Not Applicable Capital in progress primarily consisted of costs related to various leasehold improvements in connection with the new leased space that have not yet been placed into service. Depreciation and amortization expense related to property and equipment was $0.7 million and $1.1 million for the three months ended October 31, 2022 and 2021, respectively, and $1.9 million and $2.2 million for the six months ended October 31, 2022 and 2021, respectively. Accrued Compensation and Employee Benefits Accrued compensation and employee benefits consisted of the following at October 31, 2022 and April 30, 2022 (in thousands): As of October 31, As of April 30, 2022 2022 Accrued stock-settled bonus $ 20,224 $ — Accrued bonus 7,390 16,078 Accrued vacation 4,180 3,814 Accrued payroll taxes and benefits 3,846 3,593 Accrued commission 834 1,440 Accrued salaries 568 7,298 ESPP contributions 320 — Other 366 — Accrued compensation and employee benefits $ 37,728 $ 32,223 Accrued and Other Current Liabilities Accrued and other current liabilities consisted of the following at October 31, 2022 and April 30, 2022 (in thousands): As of October 31, As of April 30, 2022 2022 Liability for common stock exercised prior to vesting $ 1,361 $ 1,970 Accrued general expenses 10,552 4,972 Operating lease liabilities, current 2,558 3,613 Commissions payable to a related party 2,448 2,510 Other 2,966 1,809 Accrued and other current liabilities $ 19,885 $ 14,874

Commitments and Contingencies

Commitments and Contingencies	6 Months Ended
	Oct. 31, 2022
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Non-cancellable Purchase Commitments The Company entered into a non-cancellable arrangement with a web-hosting services provider in November 2019. Under the arrangement, the Company committed to spend an aggregate of at least $30.0 million between November 2019 and November 2022, with a minimum amount of $10.0 million in each of the three years, on services with this vendor. The Company has incurred costs totaling $3.9 million and $3.4 million during the three months ended October 31, 2022 and 2021, respectively, and $8.0 million and $6.6 million during the six months ended October 31, 2022 and 2021, respectively, under the arrangement. The Company entered into a non-cancellable arrangement with a cloud services provider in July 2022. Under the arrangement, the Company committed to spend an aggregate of at least $100.0 million for the period of three years beginning July 2022, on services with this vendor. The Company has incurred costs totaling $1.3 million and $1.6 million during the three and six months ended October 31, 2022, respectively, under the arrangement. C3.ai Digital Transformation Institute Grants In February 2020, the Company entered into an agreement establishing the C3.ai Digital Transformation Institute (“C3.ai DTI”), a program established to attract many of the world’s leading research institutions to join in a coordinated and innovative effort to advance the digital transformation of business, government, and society. As part of the agreement, the Company has agreed to issue grants to C3.ai DTI, which are subject to compliance with certain obligations. The grants shall be paid by the Company over five years in the form of cash, publicly traded securities, or other property of equivalent net value. As of October 31, 2022 and April 30, 2022, the total potential remaining contributions are $31.6 million and $31.6 million, respectively. The future grant payments are conditional in nature and subject to execution of the program in line with specific requirements. Leases On August 25, 2021, the Company entered into a new lease to acquire approximately 283,015 square feet of office space in several phases in Redwood City, California. Total undiscounted base rent payments over the term of this lease are approximately $103.1 million. In addition to base rent, the Company will be responsible for the Company’s allocated share of costs incurred and expenditures made by the landlord in the operation and management of the leased space. Under the terms of the lease agreement, the Company has a rent abatement with respect to each phase for the initial six months following the rent commencement date for such phase, with initial monthly base rent payments expected to commence April 1, 2023, which will be approximately $0.5 million at commencement and will increase up to a maximum monthly base rent of approximately $1.0 million. The lease agreement also includes an aggregate tenant improvement allowance of $44.2 million for certain costs. The term of the lease is 126 months from the date that rent commences with respect to phase one of the leased space, which will be nine months after the date when phase one of the leased space is delivered to the Company. Pursuant to the lease agreement, the Company provided the landlord an unconditional and irrevocable letter of credit of $12.6 million, which is subject to reduction pursuant to the terms of the lease agreement. The lease commencement date of the first two phases was determined to have occurred in the quarter ended January 31, 2022, when the landlord delivered the leased space to the Company. The Company recorded $26.5 million of lease liability in other long-term liabilities and corresponding right-of-use asset in other assets, non-current in the condensed consolidated balance sheets. The lease commencement date of the third phase was determined to have occurred in the quarter ended October 31, 2022, when the landlord delivered the leased space to the Company. The Company recorded $2.7 million of lease liability in other long-term liabilities and corresponding right-of-use asset in other assets, non-current in the condensed consolidated balance sheets. Legal Proceedings The Company is involved in various legal proceedings and periodically receives claims arising in the ordinary course of business. In the Company’s opinion, resolution of these matters is not expected to have a material adverse impact on its condensed consolidated statement of operations, cash flows, or balance sheet. Securities Litigation On March 4, 2022, a putative securities class action complaint (captioned The Reckstin Family Trust v. C3.ai, Inc. et al., 22-cv-01413-HSG) was filed in the U.S. District Court for the Northern District of California against the Company, and certain current and former officers and directors. The complaint generally alleges that the defendants made material misstatements or omissions about the Company’s partnership with Baker Hughes and other strategic alliances, the Company’s market potential, and the uptake of the Company’s products. The complaint alleges that defendants made these misstatements or omissions in connection with the Company’s initial public offering (“IPO”) in violation of Sections 11 and 15 of the Securities Act of 1933 and between December 9, 2020 and February 15, 2022, inclusive, in violation of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934. The complaint seeks unspecified damages, interest, fees and costs. Additionally, on May 23, 2022, a putative shareholder derivative action (captioned Suri v. Siebel et al., 22-cv-03031) was filed in the U.S. District Court for the Northern District of California. The plaintiff asserts claims on the Company’s behalf against certain of the Company’s officers and directors for breach of fiduciary duty, gross mismanagement, abuse of control, unjust enrichment, and contribution under the Securities Exchange Act of 1934 based on allegations similar to those in the securities class action. The Company is named as a nominal defendant. The derivative complaint seeks unspecified damages, an award of costs and expenses, including reasonable attorneys’ fees, and corporate governance reforms. On September 7, 2022, the derivative action was stayed pending resolution of the securities class action. The Company does not believe the claims have merit. As of the date of this report, the Company does not believe it is probable that these cases will result in an unfavorable outcome; however, if an unfavorable outcome were to occur in these cases, it is possible that the impact could be material to the Company's results of operations in the period(s) in which any such outcome becomes probable and estimable. In addition, from time to time, the Company is involved in various other legal proceedings arising in the ordinary course of business. Apart from the foregoing, the Company is not presently a party to any other such litigation the outcome of which, the Company believes, if determined adversely to the Company, would individually, or taken together, have a material adverse effect on the Company’s business, operating results, cash flows, or financial condition.

Stockholders' Equity

Stockholders' Equity	6 Months Ended
	Oct. 31, 2022
Equity [Abstract]
Stockholders' Equity	Stockholders’ Equity Preferred Stock The Company has authorized the issuance of 200,000,000 shares of undesignated preferred stock with a par value of $0.001 per share with rights and preferences, including voting rights, designated from time to time by the board of directors. As of October 31, 2022, there were no shares of Preferred Stock issued or outstanding. Common Stock The Company has authorized the issuance of 1,000,000,000 shares of Class A common stock and 3,500,000 shares of Class B common stock. The shares of Class A common stock and Class B common stock are identical, except with respect to voting, conversion, and transfer rights. Each share of Class A common stock is entitled to one vote. Each share of Class B common stock is entitled to 50 votes. Class A and Class B common stock have a par value of $0.001 per share and are referred to as common stock throughout the notes to the unaudited condensed consolidated financial statements, unless otherwise noted. Holders of common stock are entitled to receive any dividends as may be declared from time to time by the board of directors. Shares of Class B common stock may be converted to Class A common stock at any time at the option of the stockholder. Each share of Class B common stock will be automatically converted into one share of Class A common stock upon the earliest of the following: (i) the date that is six months following the death or incapacity of Mr. Siebel; (ii) the date that is six months following the date that Mr. Siebel is no longer providing services to the Company as an officer, employee, director, or consultant; (iii) December 11, 2040, which is the twentieth anniversary of the completion of the IPO; or (iv) the date specified by the holders of a majority of the then outstanding shares of Class B common stock, voting as a separate class. Future transfers by holders of Class B common stock will generally result in those shares converting to Class A common stock. Common Stock Subject to Repurchase Under the Company’s Amended and Restated 2012 Equity Incentive Plan (the “2012 Incentive Plan”) and the Company’s Amended and Restated 2020 Equity Incentive Plan (the “2020 Incentive Plan”), certain optionholders are allowed to exercise stock options to purchase Class A common stock prior to vesting. The Company has the right to repurchase at the original purchase price any unvested but outstanding shares of common stock upon termination of service of the optionholder. The consideration received for an early exercise of a stock option is considered to be a deposit of the exercise price and the related amount is recorded as a liability. The net proceeds from the early exercise of such options were nil and nil during the three months ended October 31, 2022 and 2021, respectively, and nil and nil during the six months ended October 31, 2022 and 2021, respectively. The liability is reclassified into equity on a ratable basis as the stock options vest. Unvested Class A common stock of 247,155 and 373,790 shares as of October 31, 2022 and April 30, 2022, respectively, were subject to such repurchase right and are legally issued and outstanding as of each period presented. See Note 8. Stock-Based Compensation for more information. Stock Repurchase Program In December 2021, the Company's board of directors approved a stock repurchase program for the repurchase of up to $100.0 million of the Company’s outstanding shares of Class A common stock for the 18 months following the date of such approval. Under the program, the Company may purchase stock in the open market or through privately negotiated transactions in accordance with applicable securities laws. The timing and actual amount of the stock repurchases will depend on several factors including price, capital availability, regulatory requirements, alternative investment opportunities and other market conditions. In March 2022, the Company repurchased and immediately retired 0.7 million shares of its Class A common stock for an aggregate amount of $15.0 million. During the three and six months ended October 31, 2022, the Company has not repurchased any shares of its Class A common stock. As of October 31, 2022, $85.0 million remained available for future repurchases under the program.

Stock-Based Compensation

Stock-Based Compensation	6 Months Ended
	Oct. 31, 2022
Share-Based Payment Arrangement [Abstract]
Stock-Based Compensation	Stock-Based Compensation On November 27, 2020, the Company’s board of directors adopted, and its stockholders approved, the 2020 Incentive Plan, which became effective in connection with the IPO. The 2020 Incentive Plan provides for the grant of incentive stock options, nonstatutory stock options, stock appreciation rights, restricted stock awards, restricted stock unit (“RSU”) awards, performance awards and other equity awards. The number of shares of Class A common stock reserved for issuance under the 2020 Incentive Plan is subject to automatic evergreen increases annually through (and including) May 1, 2030 pursuant to the terms of the 2020 Incentive Plan. There was an automatic annual increase on May 1, 2022 in the number of shares reserved for future issuance pursuant to the 2020 Incentive Plan in an amount equal to five percent (5%) of the total number of shares of the Company’s Class A common stock and Class B common stock outstanding on April 30, 2022. Stock Options to Acquire Class A Common Stock Stock options generally expire 10 years from the date of grant, or earlier if services are terminated. Generally, each stock option for common stock is subject to a vesting schedule such that one fifth of the award vests after the first-year anniversary and one-sixtieth of the award vests each month thereafter over the remaining four years, subject to continuous service. A summary of the Company’s option activity during the six months ended October 31, 2022 is as follows: Options Outstanding Number of Weighted Weighted Aggregate (in thousands) (in thousands) Balance as of April 30, 2022 36,338 $ 12.44 7.34 $ 165,436 Options granted 511 13.74 Options exercised (577) 16.34 Options cancelled (357) 13.65 Balance as of October 31, 2022 35,915 $ 12.59 6.93 $ 18,676 Vested and exercisable as of October 31, 2022 19,126 $ 7.50 6.15 $ 107,300 Vested and expected to vest as of October 31, 2022 (1) 36,162 $ 12.59 6.93 $ 18,804 (1) The number of options vested and expected to vest as of October 31, 2022 includes early exercised, unvested Class A common stock. Refer to Note 7. Stockholders’ Equit y for more information. As of October 31, 2022, there was $131.0 million of unrecognized compensation cost related to stock options which are expected to be recognized over an estimated weighted-average period of 2.9 years. The grant-date fair value of the options issued for the six months ended October 31, 2022 is estimated on the date of grant using the Black-Scholes-Merton option pricing model. The weighted average assumptions underlying the fair value estimation are provided in the following table: As of October 31, 2022 2021 Valuation assumptions: Expected dividend yield — % — % Expected volatility 46.4 % 43.9 % Expected term (years) 6.5 6.5 Risk-free interest rate 3.8 % 1.0 % Restricted Stock Units The RSUs are typically subject to service-based vesting conditions satisfied over five years with one-fifth of the award vesting after the first-year anniversary and one-twenty-fifth of the award vesting quarterly thereafter. The related stock-based compensation is recognized on a straight-line basis over the requisite service period. A summary of the Company’s RSU activity during the six months ended October 31, 2022 is as follows: RSUs Outstanding Number of RSUs Weighted Average (in thousands) Unvested Balance as of April 30, 2022 12,109 $ 36.04 RSUs granted 11,212 17.77 RSUs vested (3,529) 33.63 RSUs forfeited (2,221) 34.22 Unvested Balance as of October 31, 2022 17,571 $ 25.05 As of October 31, 2022, there was $414.4 million of unrecognized stock-based compensation expense related to outstanding RSUs granted to employees that is expected to be recognized over a weighted-average period of 3.8 years. In June 2022, the Compensation Committee of the board of directors approved the payment of fiscal year 2022 bonuses under the Company’s annual bonus program by issuing shares of restricted Class A common stock to employees. The Company issued 811,790 shares of restricted Class A common stock pursuant to this program in the six months ended October 31, 2022. Shares issued under this bonus program were issued from the 2020 Incentive Plan and reduced the shares available for issuance under the 2020 Incentive Plan. Starting fiscal year 2023, the Company records stock-based compensation associated with the Company’s annual bonus program that will be settled by shares of restricted Class A common stock. Employee Stock Purchase Plan On November 27, 2020, the Company’s board of directors also adopted, and its stockholders also approved, the 2020 Employee Stock Purchase Plan (the “2020 ESPP”), which became effective immediately prior to the IPO. The 2020 ESPP authorizes the issuance of shares of Class A common stock pursuant to purchase rights granted to employees. A total of 3,000,000 shares of Class A common stock were initially reserved for future issuance under the 2020 ESPP. The number of shares of Class A common stock reserved for issuance under the 2020 ESPP is subject to automatic evergreen increases annually through (and including) May 1, 2030 pursuant to the terms of the 2020 ESPP. There was an automatic annual increase on May 1, 2022 in the number of shares reserved for future issuance pursuant to the 2020 ESPP in an amount equal to one percent (1%) of the total number of shares of the Company’s Class A common stock and Class B common stock outstanding on April 30, 2022. The 2020 ESPP permits participants to purchase shares of Class A common stock in an amount not exceeding 15% of their earnings during the relevant offering period. The offering dates and purchase dates for the 2020 ESPP are determined at the discretion of the Company’s board of directors. Except for the initial offering period under the 2020 ESPP, which commenced on October 16, 2022 and ends on September 15, 2024, the 2020 ESPP provides for 24-month offering periods beginning September 15 and March 15 of each year, with each offering period consisting of four six-month purchase periods. The 2020 ESPP allows eligible employees to purchase shares of the Company’s Class A common stock, subject to purchase limits of 2,500 shares during each six-month period or $25,000 worth of stock for each calendar year, through payroll deductions at price per share equal to 85% of the lesser of the fair market value of the Company’s Class A common stock on (i) the first trading day of the applicable offering period and (ii) the last trading day of each purchase period in the applicable offering period. If the price per share of the Company’s Class A common stock on any purchase date in the offering period is lower than the price per share of the Company’s Class A common stock price on the enrollment date of that offering period, the offering period will immediately reset after the purchase of shares on such purchase date and automatically roll into a new 24-month offering period. The Company uses a Black-Scholes-Merton option pricing model to determine the fair value of employee stock purchase rights granted under the 2020 ESPP. During the six months ended October 31, 2022 and 2021, the Company recognized $0.3 million and nil, respectively, of stock-based compensation expense related to 2020 ESPP. As of October 31, 2022, there was $6.1 million of unrecognized stock-based compensation expense that is expected to be recognized over the remaining term of the respective offering periods. The following assumptions were used to calculate the fair value of shares to be granted under the 2020 ESPP during the period: As of October 31, 2022 Valuation assumptions: Expected dividend yield — % Expected volatility 47.8 - 61.4% Expected term (years) 0.4 - 1.9 Risk-free interest rate 4.3 - 4.5% Stock-based Compensation Expense The following table summarizes the effects of stock-based compensation on the Company’s condensed consolidated statements of operations (in thousands): Three Months Ended October 31, Six Months Ended October 31, 2022 2021 2022 2021 Cost of subscription $ 5,486 $ 2,364 $ 9,758 $ 3,185 Cost of professional services 479 685 1,550 1,287 Sales and marketing 19,080 13,555 35,859 19,690 Research and development 23,905 10,256 49,122 13,014 General and administrative 7,063 5,680 16,354 9,276 Total stock-based compensation expense $ 56,013 $ 32,540 $ 112,643 $ 46,452

Income Taxes

Income Taxes	6 Months Ended
	Oct. 31, 2022
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes Accounting for income taxes for interim periods generally requires the provision for income taxes to be determined by applying an estimate of the annual effective tax rate for the full fiscal year to income or loss before income taxes, adjusted for discrete items, if any, for the reporting period. The Company updates its estimate of the annual effective tax rate each quarter and makes a cumulative adjustment in such period. The Company recorded income tax expense of $0.2 million and nil for the three months ended October 31, 2022 and 2021, respectively, and $0.3 million and $0.4 million for the six months ended October 31, 2022 and 2021, respectively. Income tax expense consists primarily of income taxes in foreign jurisdictions in which the Company conducts business. Due to the Company’s history of losses in the United States, a full valuation allowance on substantially all of the Company’s deferred tax assets, including net operating loss carryforwards, research and development tax credits, and other book versus tax differences, was maintained.

Net Loss Per Share Attributable

Net Loss Per Share Attributable to Common Stockholders	6 Months Ended
	Oct. 31, 2022
Earnings Per Share [Abstract]
Net Loss Per Share Attributable to Common Stockholders	Net Loss Per Share Attributable to Common Stockholders Basic and diluted net loss per share attributable to common stockholders is presented in conformity with the two-class method required for participating securities. The rights, including the liquidation and dividend rights, of the holders of Class A and Class B common stock are identical, except with respect to voting and conversion. As the liquidation and dividend rights are identical, the undistributed earnings are allocated on a proportionate basis and the resulting net loss per share will, therefore, be the same for both Class A and Class B common stock on an individual or combined basis. Basic net loss per share attributable to common stockholders is computed by dividing the net loss by the weighted-average number of shares of common stock outstanding during the period, less shares subject to repurchase. Diluted net loss per share attributable to common stockholders is computed by giving effect to all potential dilutive common stock equivalents outstanding for the period to the extent they are dilutive. For purposes of this calculation, stock options, RSUs, Class A common stock issuable in connection with the 2020 ESPP and early exercised stock options subject to repurchase are considered to be potential common stock equivalents but have been excluded from the calculation of diluted net loss per share attributable to common stockholders as their effect is anti-dilutive. Basic net loss per share was the same as diluted net loss per share for the periods presented because the Company was in a loss position for the three and six months ended October 31, 2022 and 2021. The following table sets forth the computation of basic and diluted net loss per share attributable to common stockholders (in thousands, except per share data): Three Months Ended October 31, Six Months Ended October 31, 2022 2021 2022 2021 Numerator Net loss attributable to common stockholders $ (68,850) $ (56,739) $ (140,721) $ (94,198) Denominator Basic and diluted weighted-average Class A common stock outstanding 105,376 100,246 104,385 99,558 Basic and diluted weighted-average Class B common stock outstanding 3,500 3,500 3,500 3,500 Basic and diluted net loss per share attributable to common stockholders Basic and diluted net loss per Class A common stock outstanding $ (0.63) $ (0.55) $ (1.30) $ (0.91) Basic and diluted net loss per Class B common stock outstanding $ (0.63) $ (0.55) $ (1.30) $ (0.91) The potential shares of common stock that were excluded from the computation of diluted net loss per share attributable to common stockholders for the period presented because including them would have had an antidilutive effect were as follows: As of October 31, 2022 2021 Stock options 36,162,330 37,824,606 RSUs 17,570,508 6,041,895

Related Party Transactions

Related Party Transactions	6 Months Ended
	Oct. 31, 2022
Related Party Transactions [Abstract]
Related Party Transactions	Related Party Transactions Revenue Transactions with Baker Hughes Company In June 2019, the Company entered into multiple agreements with Baker Hughes Company (“Baker Hughes”) under which Baker Hughes received a three-year subscription to use the Company’s software. These agreements were revised in June 2020 to extend the term to five years and modify the subscription fees due. Under the agreements as revised in June 2020, Baker Hughes made minimum, non-cancellable revenue commitments, inclusive of their direct subscription fees and third-party revenue generated through a joint marketing arrangement with Baker Hughes, in the amount of $46.7 million in fiscal year 2020, $53.3 million in fiscal year 2021, $75.0 million in fiscal year 2022, $125.0 million in fiscal year 2023, and $150.0 million in fiscal year 2024. The Company also agreed to pay Baker Hughes a sales commission on subscriptions and services offerings it resold in excess of these minimum revenue commitments. The Company and Baker Hughes further revised these agreements in October 2021 to extend the term by an additional year, for a total of six years, with an expiration date in the fiscal year ending April 30, 2025, to modify the amount of Baker Hughes’ annual commitments to $85.0 million in fiscal year 2023, $110.0 million in fiscal year 2024, and $125.0 million in fiscal year 2025, and to revise the structure of the arrangement to further incentivize Baker Hughes’ sales of the Company’s products and services. A portion of the transaction price in the Company’s arrangement with Baker Hughes is variable. Beginning in the fiscal year ending April 30, 2023, Baker Hughes’ annual commitments will be reduced by any revenue the Company generates from certain customers. Known and estimable revenue from certain customers related to the arrangement is a form of variable consideration, which was determined at contract inception and reduces the revenue recognized from the arrangement. At the end of each reporting period, the Company reviews and updates the estimate as additional information becomes available. Pursuant to the revised arrangement, the Company acknowledged that Baker Hughes had met its minimum annual revenue commitment for the fiscal year 2022 and recognized $16.0 million of sales commission as deferred costs during the fiscal quarter ended October 31, 2021 related to this arrangement, which will be amortized over an expected period of five years. Revenue recognized under the arrangement were as follows (in thousands): Three Months Ended October 31, Six Months Ended October 31, 2022 2021 2022 2021 Direct subscription $ 19,238 $ 10,012 $ 35,568 $ 20,220 Direct professional services 21 5,924 150 7,998 Total revenue from direct subscription and professional services 19,259 15,936 35,718 28,218 Total revenue from certain customers in Oil and Gas field related to the Baker Hughes arrangement 8,159 4,617 15,269 8,484 Total revenue related to the arrangement $ 27,418 $ 20,553 $ 50,987 $ 36,702 As of October 31, 2022 and April 30, 2022, balances related to Baker Hughes that are reported within accounts receivable, net (inclusive of unbilled receivables of $53.0 million and $16.5 million, respectively) included $53.9 million and $35.8 million, respectively, and deferred revenue, current included $0.4 million and $0.1 million, respectively. The Company recognized cost of subscription revenue related to services purchased from Baker Hughes of nil and $0.1 million during the three months ended October 31, 2022 and 2021, respectively, and nil and $0.2 million during the six months ended October 31, 2022 and 2021, respectively. The Company recognized sales and marketing expenses related to Baker Hughes of $3.5 million and $0.1 million during the three months ended October 31, 2022 and 2021, respectively, and $7.0 million and $0.2 million during the six months ended October 31, 2022 and 2021, respectively. As of October 31, 2022 and April 30, 2022, accounts payable included $2.2 million and $18.5 million, respectively. The remaining performance obligations related to Baker Hughes, which includes both direct subscriptions and reseller arrangements, is comprised of (in thousands): As of October 31, 2022 2021 Deferred revenue $ 387 $ 18,712 Commitments from non-cancellable contracts 184,550 282,325 Total remaining performance obligations $ 184,937 $ 301,037 As of October 31, 2022 and April 30, 2022, the current portion of deferred costs of $4.9 million and $4.9 million, respectively, were included in prepaid expenses and other current assets, and the non-current portion of $13.7 million and $16.1 million, respectively, were included in other assets, non-current. The Company amortized $1.2 million and $0.4 million of deferred commissions during the three months ended October 31, 2022 and 2021, respectively, and $2.4 million and $0.8 million of deferred commissions during the six months ended October 31, 2022 and 2021, respectively. These amounts were included in sales and marketing expense in the condensed consolidated statements of operations. The Company paid sales commission of $16.0 million and $3.4 million during the six months ended October 31, 2022 and 2021, respectively, related to this arrangement. As of October 31, 2022 and April 30, 2022, accrued and other current liabilities included $2.4 million and $2.5 million, respectively, and other long-term liabilities included nil and $2.4 million, respectively.

Summary of Business and Signi_2

Summary of Business and Significant Accounting Policies (Policies)	6 Months Ended
	Oct. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation	Basis of Presentation and Principles of Consolidation The Company prepares its unaudited condensed consolidated financial statements in accordance with generally accepted accounting principles in the United States (“U.S. GAAP”) and applicable rules and regulations of the U.S. Securities and Exchange Commission (the “SEC”) regarding interim financial reporting. Accordingly, they do not include all disclosures normally required in annual consolidated financial statements prepared in accordance with U.S. GAAP. Therefore, these unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes included in the Company’s Annual Report on Form 10-K for the fiscal year ended April 30, 2022, which was filed with the SEC on June 23, 2022. In management’s opinion, these unaudited condensed consolidated financial statements have been prepared on the same basis as the annual financial statements and reflect all adjustments, which include only normal recurring adjustments necessary for the fair statement of the Company’s financial position as of October 31, 2022 and the results of operations for the three and six months ended October 31, 2022. The results of operations for the three and six months ended October 31, 2022 are not necessarily indicative of the results to be expected for the full year or any other future interim or annual period.
Principles of Consolidation	The condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.
Use of Estimates	Use of Estimates The preparation of the accompanying unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions about future events. These estimates and the underlying assumptions affect the amounts of assets and liabilities reported, disclosures about contingent assets and liabilities, and reported amounts of revenue and expenses. Actual results and outcomes could differ significantly from the Company’s estimates, judgments, and assumptions. Significant estimates include, but are not limited to, determining standalone selling price for performance obligations in contracts with customers and estimating variable consideration, the estimated expected benefit period for deferred contract acquisition costs, the useful lives of long-lived assets, the incremental borrowing rate for operating leases and other assumptions used to measure stock-based compensation, and the valuation of deferred income tax assets and uncertain tax positions. These estimates and assumptions are based on management’s best estimates and judgment. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, which management believes to be reasonable under the circumstances. The Company adjusts such estimates and assumptions when facts and circumstances dictate. Changes in those estimates resulting from continuing changes in the economic environment will be reflected in the financial statements in future periods. As future events and their effects cannot be determined with precision, actual results could materially differ from those estimates and assumptions.
Fiscal Year	Fiscal YearThe Company’s fiscal year ends on April 30.

Revenue (Tables)

Revenue (Tables)	6 Months Ended
	Oct. 31, 2022
Revenue from Contract with Customer [Abstract]
Schedule of Revenue by Geographical Region	The following table presents revenue by geographical region (in thousands): Three Months Ended October 31, Six Months Ended October 31, 2022 2021 2022 2021 North America (1) $ 47,916 $ 43,697 $ 99,854 $ 80,149 Europe, the Middle East and Africa (1) 11,889 12,789 22,592 25,008 Asia Pacific (1) 2,435 1,777 4,802 5,512 Rest of World (1) 168 — 468 — Total revenue $ 62,408 $ 58,263 $ 127,716 $ 110,669 __________________ (1) The United States comprised 77% and 75% of the Company’s revenue for the three months ended October 31, 2022 and 2021, respectively, and 78% and 72% of the Company’s revenue for the six months ended October 31, 2022 and 2021, respectively. France comprised 12% of the Company’s revenue for the three months ended October 31, 2021, and 12% of the Company’s revenue for the six months ended October 31, 2021. No other country comprised 10% or greater of the Company’s revenue for the three and six months ended October 31, 2022 or 2021.

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	6 Months Ended
	Oct. 31, 2022
Fair Value Disclosures [Abstract]
Schedule of Assets Measured at Fair Value on a Recurring Basis	The following table summarizes the types of assets measured at fair value on a recurring basis by level within the fair value hierarchy (in thousands): As of October 31, 2022 As of April 30, 2022 Level 1 Level 2 Level 3 Total Level 1 Level 2 Level 3 Total Cash equivalents: Money market funds $ 160,068 $ — $ — $ 160,068 $ 107,726 $ — $ — $ 107,726 Certificates of deposit — — — — — 3,000 — 3,000 Commercial paper 79,664 — 79,664 — 142,511 — 142,511 Corporate debt securities — — — — — 8,884 — 8,884 Available-for-sale marketable securities: U.S. treasury securities 12,326 — 12,326 — 12,763 — 12,763 Certificates of deposit — 90,481 — 90,481 — 97,205 — 97,205 U.S. government agencies securities — 23,836 — 23,836 — 13,890 — 13,890 Commercial paper — 184,185 — 184,185 — 241,132 — 241,132 Corporate debt securities — 270,306 — 270,306 — 287,729 — 287,729 Total cash equivalents and available-for-sale marketable securities $ 160,068 $ 660,798 $ — $ 820,866 $ 107,726 $ 807,114 $ — $ 914,840

Investments (Tables)

Investments (Tables)	6 Months Ended
	Oct. 31, 2022
Investments, Debt and Equity Securities [Abstract]
Schedule of Available-For-Sale Debt Securities and Balance Sheet Classification	The following table summarizes the Company’s cash equivalents and available-for-sale marketable securities (in thousands): As of October 31, 2022 As of April 30, 2022 Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Estimated Fair Value Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Estimated Fair Value Cash equivalents: Money market funds $ 160,068 $ — $ — $ 160,068 $ 107,726 $ — $ — $ 107,726 Certificates of deposit — — 3,000 — — 3,000 Commercial paper 79,664 — — 79,664 142,511 — — 142,511 Corporate debt securities — — — — 8,889 — (5) 8,884 Available-for-sale marketable securities: U.S. treasury securities 12,381 1 (56) 12,326 12,764 — (1) 12,763 Certificates of deposit 90,481 — — 90,481 97,205 — — 97,205 U.S. government agencies securities 24,217 — (381) 23,836 14,113 — (223) 13,890 Commercial paper 184,185 — — 184,185 241,134 — (2) 241,132 Corporate debt securities 272,675 3 (2,372) 270,306 289,646 20 (1,937) 287,729 Total cash equivalents and available-for-sale marketable securities $ 823,671 $ 4 $ (2,809) $ 820,866 $ 916,988 $ 20 $ (2,168) $ 914,840
Summary of Available-For-Sale Debt Securities by Contractual Maturity	The following table summarizes the Company’s available-for-sale marketable securities by contractual maturity (in thousands): As of October 31, 2022 As of April 30, 2022 Amortized Cost Fair Value Amortized Cost Fair Value Within one year $ 565,153 $ 562,448 $ 622,517 $ 620,633 After one year through five years 18,784 18,686 32,345 32,086 Total $ 583,937 $ 581,134 $ 654,862 $ 652,719
Summary of Available-For-Sale Marketable Securities, Fair Values and Unrealized Losses	The following table summarizes the fair values and unrealized losses of the Company’s available-for-sale marketable securities classified by length of time that the securities have been in a continuous unrealized loss position but were not deemed to be other-than-temporarily impaired, as of October 31, 2022 (in thousands): As of October 31, 2022 Less Than 12 Months 12 Months or Greater Total Unrealized Losses Fair Value Unrealized Losses Fair Value Unrealized Losses Fair Value U.S. treasury securities $ (56) $ 12,325 $ — $ — $ (56) $ 12,325 U.S. government agencies securities (381) 23,836 — — (381) 23,836 Commercial paper — 3,022 — — — 3,022 Corporate debt securities (2,270) 247,254 (102) 10,503 (2,372) 257,757 Total $ (2,707) $ 286,437 $ (102) $ 10,503 $ (2,809) $ 296,940

Balance Sheet Details (Tables)

Balance Sheet Details (Tables)	6 Months Ended
	Oct. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Schedule of Property and Equipment, Net	Property and equipment consisted of the following at October 31, 2022 and April 30, 2022 (in thousands): Useful Life As of October 31, As of April 30, (in months) 2022 2022 Leasehold improvements * $ 8,878 $ 8,878 Computer equipment 36 4,304 3,321 Office furniture and equipment 60 381 348 Capital in progress NA 59,320 11,261 Property and equipment—gross 72,883 23,808 Less: accumulated depreciation and amortization (11,159) (9,291) Property and equipment—net $ 61,724 $ 14,517 __________________ * Leasehold improvements are amortized over the shorter of the estimated useful lives of the improvements or the remaining lease term. NA = Not Applicable
Schedule of Accrued Compensation and Employee Benefits	Accrued compensation and employee benefits consisted of the following at October 31, 2022 and April 30, 2022 (in thousands): As of October 31, As of April 30, 2022 2022 Accrued stock-settled bonus $ 20,224 $ — Accrued bonus 7,390 16,078 Accrued vacation 4,180 3,814 Accrued payroll taxes and benefits 3,846 3,593 Accrued commission 834 1,440 Accrued salaries 568 7,298 ESPP contributions 320 — Other 366 — Accrued compensation and employee benefits $ 37,728 $ 32,223
Schedule of Accrued and Other Current Liabilities	Accrued and other current liabilities consisted of the following at October 31, 2022 and April 30, 2022 (in thousands): As of October 31, As of April 30, 2022 2022 Liability for common stock exercised prior to vesting $ 1,361 $ 1,970 Accrued general expenses 10,552 4,972 Operating lease liabilities, current 2,558 3,613 Commissions payable to a related party 2,448 2,510 Other 2,966 1,809 Accrued and other current liabilities $ 19,885 $ 14,874

Stock-Based Compensation (Table

Stock-Based Compensation (Tables)	6 Months Ended
	Oct. 31, 2022
Share-Based Payment Arrangement [Abstract]
Summary of Stock Option Activity	A summary of the Company’s option activity during the six months ended October 31, 2022 is as follows: Options Outstanding Number of Weighted Weighted Aggregate (in thousands) (in thousands) Balance as of April 30, 2022 36,338 $ 12.44 7.34 $ 165,436 Options granted 511 13.74 Options exercised (577) 16.34 Options cancelled (357) 13.65 Balance as of October 31, 2022 35,915 $ 12.59 6.93 $ 18,676 Vested and exercisable as of October 31, 2022 19,126 $ 7.50 6.15 $ 107,300 Vested and expected to vest as of October 31, 2022 (1) 36,162 $ 12.59 6.93 $ 18,804 (1) The number of options vested and expected to vest as of October 31, 2022 includes early exercised, unvested Class A common stock. Refer to Note 7. Stockholders’ Equit y for more information.
Schedule of Valuation Assumptions	The weighted average assumptions underlying the fair value estimation are provided in the following table: As of October 31, 2022 2021 Valuation assumptions: Expected dividend yield — % — % Expected volatility 46.4 % 43.9 % Expected term (years) 6.5 6.5 Risk-free interest rate 3.8 % 1.0 %
Schedule of Restricted Stock Unit Activity	A summary of the Company’s RSU activity during the six months ended October 31, 2022 is as follows: RSUs Outstanding Number of RSUs Weighted Average (in thousands) Unvested Balance as of April 30, 2022 12,109 $ 36.04 RSUs granted 11,212 17.77 RSUs vested (3,529) 33.63 RSUs forfeited (2,221) 34.22 Unvested Balance as of October 31, 2022 17,571 $ 25.05
Schedule of Valuation Assumptions	The following assumptions were used to calculate the fair value of shares to be granted under the 2020 ESPP during the period: As of October 31, 2022 Valuation assumptions: Expected dividend yield — % Expected volatility 47.8 - 61.4% Expected term (years) 0.4 - 1.9 Risk-free interest rate 4.3 - 4.5%
Summary of Effects of Stock-Based Compensation	The following table summarizes the effects of stock-based compensation on the Company’s condensed consolidated statements of operations (in thousands): Three Months Ended October 31, Six Months Ended October 31, 2022 2021 2022 2021 Cost of subscription $ 5,486 $ 2,364 $ 9,758 $ 3,185 Cost of professional services 479 685 1,550 1,287 Sales and marketing 19,080 13,555 35,859 19,690 Research and development 23,905 10,256 49,122 13,014 General and administrative 7,063 5,680 16,354 9,276 Total stock-based compensation expense $ 56,013 $ 32,540 $ 112,643 $ 46,452

Net Loss Per Share Attributab_2

Net Loss Per Share Attributable to Common Stockholders (Tables)	6 Months Ended
	Oct. 31, 2022
Earnings Per Share [Abstract]
Schedule of Basic and Diluted Net Loss Per Share	The following table sets forth the computation of basic and diluted net loss per share attributable to common stockholders (in thousands, except per share data): Three Months Ended October 31, Six Months Ended October 31, 2022 2021 2022 2021 Numerator Net loss attributable to common stockholders $ (68,850) $ (56,739) $ (140,721) $ (94,198) Denominator Basic and diluted weighted-average Class A common stock outstanding 105,376 100,246 104,385 99,558 Basic and diluted weighted-average Class B common stock outstanding 3,500 3,500 3,500 3,500 Basic and diluted net loss per share attributable to common stockholders Basic and diluted net loss per Class A common stock outstanding $ (0.63) $ (0.55) $ (1.30) $ (0.91) Basic and diluted net loss per Class B common stock outstanding $ (0.63) $ (0.55) $ (1.30) $ (0.91)
Schedule of Potential Shares of Common Stock Excluded from Computation of Basic and Diluted Net Loss Per Share	The potential shares of common stock that were excluded from the computation of diluted net loss per share attributable to common stockholders for the period presented because including them would have had an antidilutive effect were as follows: As of October 31, 2022 2021 Stock options 36,162,330 37,824,606 RSUs 17,570,508 6,041,895

Related Party Transactions (Tab

Related Party Transactions (Tables)	6 Months Ended
	Oct. 31, 2022
Related Party Transactions [Abstract]
Schedule of Related Party Transactions	Revenue recognized under the arrangement were as follows (in thousands): Three Months Ended October 31, Six Months Ended October 31, 2022 2021 2022 2021 Direct subscription $ 19,238 $ 10,012 $ 35,568 $ 20,220 Direct professional services 21 5,924 150 7,998 Total revenue from direct subscription and professional services 19,259 15,936 35,718 28,218 Total revenue from certain customers in Oil and Gas field related to the Baker Hughes arrangement 8,159 4,617 15,269 8,484 Total revenue related to the arrangement $ 27,418 $ 20,553 $ 50,987 $ 36,702 The remaining performance obligations related to Baker Hughes, which includes both direct subscriptions and reseller arrangements, is comprised of (in thousands): As of October 31, 2022 2021 Deferred revenue $ 387 $ 18,712 Commitments from non-cancellable contracts 184,550 282,325 Total remaining performance obligations $ 184,937 $ 301,037

Revenue - Disaggregated Revenue

Revenue - Disaggregated Revenue by Geographic Region (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Oct. 31, 2022	Oct. 31, 2021	Oct. 31, 2022	Oct. 31, 2021
Disaggregation of Revenue [Line Items]
Total revenue	$ 62,408	$ 58,263	$ 127,716	$ 110,669
North America
Disaggregation of Revenue [Line Items]
Total revenue	$ 47,916	$ 43,697	$ 99,854	$ 80,149
United States | Revenue | Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Geographic concentration risk, percentage	77%	75%	78%	72%
Europe, the Middle East and Africa
Disaggregation of Revenue [Line Items]
Total revenue	$ 11,889	$ 12,789	$ 22,592	$ 25,008
France | Revenue | Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Geographic concentration risk, percentage		12%		12%
Asia Pacific
Disaggregation of Revenue [Line Items]
Total revenue	2,435	$ 1,777	4,802	$ 5,512
Rest of World
Disaggregation of Revenue [Line Items]
Total revenue	$ 168	$ 0	$ 468	$ 0

Revenue - Deferred Revenue (Det

Revenue - Deferred Revenue (Details) - USD ($) $ in Millions	6 Months Ended
	Oct. 31, 2022	Oct. 31, 2021	Apr. 30, 2022
Revenue from Contract with Customer [Abstract]
Deferred revenue	$ 30.6		$ 49.1
Revenue recognized	$ 39.5	$ 56.9

Revenue - Remaining Performance

Revenue - Remaining Performance Obligation (Details) $ in Millions	Oct. 31, 2022 USD ($)
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue expected to be recognized from remaining performance obligations, amount	$ 417.3
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-11-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue expected to be recognized from remaining performance obligations, amount	$ 164.5
Revenue expected to be recognized from remaining performance obligations, period	12 months

Revenue - Customer Concentratio

Revenue - Customer Concentration and Accounts Receivable (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended		12 Months Ended
	Oct. 31, 2022	Oct. 31, 2021	Oct. 31, 2022	Oct. 31, 2021	Apr. 30, 2022
Disaggregation of Revenue [Line Items]
Unbilled receivables	$ 65.1		$ 65.1		$ 19.9
Customer Concentration Risk | Revenue | Customer One
Disaggregation of Revenue [Line Items]
Customer concentration risk, percentage	32%	28%	29%	25%
Customer Concentration Risk | Revenue | Customer Two
Disaggregation of Revenue [Line Items]
Customer concentration risk, percentage		11%		12%
Customer Concentration Risk | Accounts Receivable | Customer One
Disaggregation of Revenue [Line Items]
Customer concentration risk, percentage			26%		32%
Customer Concentration Risk | Accounts Receivable | Customer Two
Disaggregation of Revenue [Line Items]
Customer concentration risk, percentage			11%		13%
Customer Concentration Risk | Accounts Receivable | Customer Three
Disaggregation of Revenue [Line Items]
Customer concentration risk, percentage					12%

Fair Value Measurements - Asset

Fair Value Measurements - Assets Measured at Fair Value on a Recurring Basis (Details) - USD ($) $ in Thousands	Oct. 31, 2022	Apr. 30, 2022
Available-for-sale marketable securities:
Total cash equivalents and available-for-sale marketable securities	$ 820,866	$ 914,840
Money market funds
Cash equivalents:
Estimated Fair Value	160,068	107,726
Certificates of deposit
Cash equivalents:
Estimated Fair Value	0	3,000
Available-for-sale marketable securities:
Available-for-sale marketable securities, fair value	90,481	97,205
U.S. treasury securities
Available-for-sale marketable securities:
Available-for-sale marketable securities, fair value	12,326	12,763
U.S. government agencies securities
Available-for-sale marketable securities:
Available-for-sale marketable securities, fair value	23,836	13,890
Commercial paper
Cash equivalents:
Estimated Fair Value	79,664	142,511
Available-for-sale marketable securities:
Available-for-sale marketable securities, fair value	184,185	241,132
Corporate debt securities
Cash equivalents:
Estimated Fair Value	0	8,884
Available-for-sale marketable securities:
Available-for-sale marketable securities, fair value	270,306	287,729
Fair Value, Recurring
Available-for-sale marketable securities:
Total cash equivalents and available-for-sale marketable securities	820,866	914,840
Fair Value, Recurring | Money market funds
Cash equivalents:
Estimated Fair Value	160,068	107,726
Fair Value, Recurring | Certificates of deposit
Cash equivalents:
Estimated Fair Value	0	3,000
Available-for-sale marketable securities:
Available-for-sale marketable securities, fair value	90,481	97,205
Fair Value, Recurring | U.S. treasury securities
Available-for-sale marketable securities:
Available-for-sale marketable securities, fair value	12,326	12,763
Fair Value, Recurring | U.S. government agencies securities
Available-for-sale marketable securities:
Available-for-sale marketable securities, fair value	23,836	13,890
Fair Value, Recurring | Commercial paper
Cash equivalents:
Estimated Fair Value	79,664	142,511
Available-for-sale marketable securities:
Available-for-sale marketable securities, fair value	184,185	241,132
Fair Value, Recurring | Corporate debt securities
Cash equivalents:
Estimated Fair Value	0	8,884
Available-for-sale marketable securities:
Available-for-sale marketable securities, fair value	270,306	287,729
Fair Value, Recurring | Level 1
Available-for-sale marketable securities:
Total cash equivalents and available-for-sale marketable securities	160,068	107,726
Fair Value, Recurring | Level 1 | Money market funds
Cash equivalents:
Estimated Fair Value	160,068	107,726
Fair Value, Recurring | Level 1 | Certificates of deposit
Cash equivalents:
Estimated Fair Value	0	0
Available-for-sale marketable securities:
Available-for-sale marketable securities, fair value	0	0
Fair Value, Recurring | Level 1 | U.S. treasury securities
Available-for-sale marketable securities:
Available-for-sale marketable securities, fair value		0
Fair Value, Recurring | Level 1 | U.S. government agencies securities
Available-for-sale marketable securities:
Available-for-sale marketable securities, fair value	0	0
Fair Value, Recurring | Level 1 | Commercial paper
Cash equivalents:
Estimated Fair Value		0
Available-for-sale marketable securities:
Available-for-sale marketable securities, fair value	0	0
Fair Value, Recurring | Level 1 | Corporate debt securities
Cash equivalents:
Estimated Fair Value	0	0
Available-for-sale marketable securities:
Available-for-sale marketable securities, fair value	0	0
Fair Value, Recurring | Level 2
Available-for-sale marketable securities:
Total cash equivalents and available-for-sale marketable securities	660,798	807,114
Fair Value, Recurring | Level 2 | Money market funds
Cash equivalents:
Estimated Fair Value	0	0
Fair Value, Recurring | Level 2 | Certificates of deposit
Cash equivalents:
Estimated Fair Value	0	3,000
Available-for-sale marketable securities:
Available-for-sale marketable securities, fair value	90,481	97,205
Fair Value, Recurring | Level 2 | U.S. treasury securities
Available-for-sale marketable securities:
Available-for-sale marketable securities, fair value	12,326	12,763
Fair Value, Recurring | Level 2 | U.S. government agencies securities
Available-for-sale marketable securities:
Available-for-sale marketable securities, fair value	23,836	13,890
Fair Value, Recurring | Level 2 | Commercial paper
Cash equivalents:
Estimated Fair Value	79,664	142,511
Available-for-sale marketable securities:
Available-for-sale marketable securities, fair value	184,185	241,132
Fair Value, Recurring | Level 2 | Corporate debt securities
Cash equivalents:
Estimated Fair Value	0	8,884
Available-for-sale marketable securities:
Available-for-sale marketable securities, fair value	270,306	287,729
Fair Value, Recurring | Level 3
Available-for-sale marketable securities:
Total cash equivalents and available-for-sale marketable securities	0	0
Fair Value, Recurring | Level 3 | Money market funds
Cash equivalents:
Estimated Fair Value	0	0
Fair Value, Recurring | Level 3 | Certificates of deposit
Cash equivalents:
Estimated Fair Value	0	0
Available-for-sale marketable securities:
Available-for-sale marketable securities, fair value	0	0
Fair Value, Recurring | Level 3 | U.S. treasury securities
Available-for-sale marketable securities:
Available-for-sale marketable securities, fair value	0	0
Fair Value, Recurring | Level 3 | U.S. government agencies securities
Available-for-sale marketable securities:
Available-for-sale marketable securities, fair value	0	0
Fair Value, Recurring | Level 3 | Commercial paper
Cash equivalents:
Estimated Fair Value	0	0
Available-for-sale marketable securities:
Available-for-sale marketable securities, fair value	0	0
Fair Value, Recurring | Level 3 | Corporate debt securities
Cash equivalents:
Estimated Fair Value	0	0
Available-for-sale marketable securities:
Available-for-sale marketable securities, fair value	$ 0	$ 0

Investments - Available-for-Sal

Investments - Available-for-Sale Marketable Securities (Details) - USD ($) $ in Thousands	Oct. 31, 2022	Apr. 30, 2022	Oct. 31, 2021
Cash equivalents:
Amortized Cost	$ 277,622	$ 339,528	$ 167,436
Debt Securities, Available-for-Sale [Abstract]
Total cash equivalents and available-for-sale marketable securities, Amortized Cost	823,671	916,988
Total cash equivalents and available-for-sale marketable securities, Gross Unrealized Gain	4	20
Total cash equivalents and available-for-sale marketable securities, Gross Unrealized Loss	(2,809)	(2,168)
Total cash equivalents and available-for-sale marketable securities	820,866	914,840
Money market funds
Cash equivalents:
Amortized Cost	160,068	107,726
Gross Unrealized Gains	0	0
Gross Unrealized Losses	0	0
Estimated Fair Value	160,068	107,726
U.S. treasury securities
Debt Securities, Available-for-Sale [Abstract]
Amortized Cost	12,381	12,764
Gross Unrealized Gains	1	0
Gross Unrealized Losses	(56)	(1)
Estimated Fair Value	12,326	12,763
Certificates of deposit
Cash equivalents:
Amortized Cost	0	3,000
Gross Unrealized Gains		0
Gross Unrealized Losses		0
Estimated Fair Value	0	3,000
Debt Securities, Available-for-Sale [Abstract]
Amortized Cost	90,481	97,205
Gross Unrealized Gains	0	0
Gross Unrealized Losses	0	0
Estimated Fair Value	90,481	97,205
U.S. government agencies securities
Debt Securities, Available-for-Sale [Abstract]
Amortized Cost	24,217	14,113
Gross Unrealized Gains	0	0
Gross Unrealized Losses	(381)	(223)
Estimated Fair Value	23,836	13,890
Commercial paper
Cash equivalents:
Amortized Cost	79,664	142,511
Gross Unrealized Gains	0	0
Gross Unrealized Losses	0	0
Estimated Fair Value	79,664	142,511
Debt Securities, Available-for-Sale [Abstract]
Amortized Cost	184,185	241,134
Gross Unrealized Gains	0	0
Gross Unrealized Losses	0	(2)
Estimated Fair Value	184,185	241,132
Corporate debt securities
Cash equivalents:
Amortized Cost	0	8,889
Gross Unrealized Gains	0	0
Gross Unrealized Losses	0	(5)
Estimated Fair Value	0	8,884
Debt Securities, Available-for-Sale [Abstract]
Amortized Cost	272,675	289,646
Gross Unrealized Gains	3	20
Gross Unrealized Losses	(2,372)	(1,937)
Estimated Fair Value	$ 270,306	$ 287,729

Investments - Available-for Sal

Investments - Available-for Sale Debt Securities by Contractual Maturity (Details) - Debt Securities, Available-For-Sale, Excluding Money Market Accounts - USD ($) $ in Thousands	Oct. 31, 2022	Apr. 30, 2022
Debt Securities, Available-for-sale, Amortized Cost, Fiscal Year Maturity [Abstract]
AFS Debt Maturities, Within one year, Amortized Cost	$ 565,153	$ 622,517
AFS Debt Maturities, After one year through five years, Amortized Cost	18,784	32,345
Amortized Cost	583,937	654,862
Debt Securities, Available-for-sale, Fair Value, Fiscal Year Maturity [Abstract]
AFS Debt Maturities, Within one year, Fair Value	562,448	620,633
AFS Debt Maturities, After one year through five years, Fair Value	18,686	32,086
AFS Debt Maturities, Total Fair Value	$ 581,134	$ 652,719

Investments - Available-for-S_2

Investments - Available-for-Sale Marketable Securities, Fair Value and Unrealized Losses Continuous Unrealized Loss Position (Details) $ in Thousands	Oct. 31, 2022 USD ($)
Debt Securities, Available-for-sale, Unrealized Loss Position [Line Items]
AFS, Less Than 12 Months, Unrealized Losses	$ (2,707)
AFS, Less Than 12 Months, Fair Value	286,437
AFS, 12 Months or Greater, Unrealized Losses	(102)
AFS, 12 Months or Greater, Fair Value	10,503
AFS, Total Unrealized Losses	(2,809)
AFS, Total Fair Value	296,940
U.S. treasury securities
Debt Securities, Available-for-sale, Unrealized Loss Position [Line Items]
AFS, Less Than 12 Months, Unrealized Losses	(56)
AFS, Less Than 12 Months, Fair Value	12,325
AFS, 12 Months or Greater, Unrealized Losses	0
AFS, 12 Months or Greater, Fair Value	0
AFS, Total Unrealized Losses	(56)
AFS, Total Fair Value	12,325
U.S. government agencies securities
Debt Securities, Available-for-sale, Unrealized Loss Position [Line Items]
AFS, Less Than 12 Months, Unrealized Losses	(381)
AFS, Less Than 12 Months, Fair Value	23,836
AFS, 12 Months or Greater, Unrealized Losses	0
AFS, 12 Months or Greater, Fair Value	0
AFS, Total Unrealized Losses	(381)
AFS, Total Fair Value	23,836
Commercial paper
Debt Securities, Available-for-sale, Unrealized Loss Position [Line Items]
AFS, Less Than 12 Months, Unrealized Losses	0
AFS, Less Than 12 Months, Fair Value	3,022
AFS, 12 Months or Greater, Unrealized Losses	0
AFS, 12 Months or Greater, Fair Value	0
AFS, Total Unrealized Losses	0
AFS, Total Fair Value	3,022
Corporate debt securities
Debt Securities, Available-for-sale, Unrealized Loss Position [Line Items]
AFS, Less Than 12 Months, Unrealized Losses	(2,270)
AFS, Less Than 12 Months, Fair Value	247,254
AFS, 12 Months or Greater, Unrealized Losses	(102)
AFS, 12 Months or Greater, Fair Value	10,503
AFS, Total Unrealized Losses	(2,372)
AFS, Total Fair Value	$ 257,757

Investments - Narrative (Detail

Investments - Narrative (Details)	6 Months Ended
	Oct. 31, 2022 USD ($) investment	Apr. 30, 2022 investment
Investments, Debt and Equity Securities [Abstract]
Number of investment positions in unrealized loss position | investment	263	284
Other-than-temporary impairment loss | $	$ 0

Balance Sheet Details - Propert

Balance Sheet Details - Property and Equipment, Net (Details) - USD ($) $ in Thousands	6 Months Ended
	Oct. 31, 2022	Apr. 30, 2022
Property, Plant and Equipment [Line Items]
Property and equipment—gross	$ 72,883	$ 23,808
Less: accumulated depreciation and amortization	(11,159)	(9,291)
Property and equipment—net	61,724	14,517
Leasehold improvements
Property, Plant and Equipment [Line Items]
Property and equipment—gross	$ 8,878	8,878
Computer equipment
Property, Plant and Equipment [Line Items]
Useful Life	36 months
Property and equipment—gross	$ 4,304	3,321
Office furniture and equipment
Property, Plant and Equipment [Line Items]
Useful Life	60 months
Property and equipment—gross	$ 381	348
Capital in progress
Property, Plant and Equipment [Line Items]
Property and equipment—gross	$ 59,320	$ 11,261

Balance Sheet Details - Narrati

Balance Sheet Details - Narrative (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Oct. 31, 2022	Oct. 31, 2021	Oct. 31, 2022	Oct. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Depreciation expense	$ 0.7	$ 1.1	$ 1.9	$ 2.2

Balance Sheet Details - Accrued

Balance Sheet Details - Accrued Compensation and Employee Benefits (Details) - USD ($) $ in Thousands	Oct. 31, 2022	Apr. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Accrued stock-settled bonus	$ 20,224	$ 0
Accrued bonus	7,390	16,078
Accrued vacation	4,180	3,814
Accrued payroll taxes and benefits	3,846	3,593
Accrued commission	834	1,440
Accrued salaries	568	7,298
ESPP contributions	320	0
Other	366	0
Accrued compensation and employee benefits	$ 37,728	$ 32,223

Balance Sheet Details - Accru_2

Balance Sheet Details - Accrued and Other Current Liabilities (Details) - USD ($) $ in Thousands		Oct. 31, 2022	Apr. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Liability for common stock exercised prior to vesting		$ 1,361	$ 1,970
Accrued general expenses		10,552	4,972
Operating lease liabilities, current		2,558	3,613
Commissions payable to a related party		2,448	2,510
Other		2,966	1,809
Accrued and other current liabilities	[1]	$ 19,885	$ 14,874
[1]Including amounts from a related party of $2,448 and $2,510 as of October 31, 2022 and April 30, 2022, respectively.

Commitments and Contingencies (

Commitments and Contingencies (Details)		1 Months Ended			3 Months Ended		6 Months Ended
	Aug. 25, 2021 USD ($) ft² phase	Jul. 31, 2022 USD ($)	Feb. 29, 2020	Nov. 30, 2019 USD ($)	Oct. 31, 2022 USD ($) phase	Oct. 31, 2021 USD ($)	Oct. 31, 2022 USD ($) phase	Oct. 31, 2021 USD ($)	Apr. 30, 2022 USD ($)
Long-term Purchase Commitment [Line Items]
Lease, area under lease | ft²	283,015
Lease, total undiscounted base rent payments over term of lease	$ 103,100,000
Lease, term of rent abatement per phase, following rent commencement date	6 months
Lease, monthly base rent	$ 500,000
Lessee, tenant improvement allowance	$ 44,200,000
Lease, term	126 months
Lease, period after date phase one delivered	9 months
Lease, number of phases | phase	2				3		3
Operating lease, liability	$ 26,500,000				$ 2,700,000		$ 2,700,000
Operating lease, right-of-use assets	26,500,000				2,700,000		2,700,000
Landlord | Letter of Credit | Line of Credit
Long-term Purchase Commitment [Line Items]
Letter of credit outstanding	12,600,000
Maximum
Long-term Purchase Commitment [Line Items]
Lease, monthly base rent	$ 1,000,000
C3.ai DTI Grants Program
Long-term Purchase Commitment [Line Items]
Grants, payment period			5 years
Grants, potential remaining contributions					31,600,000		31,600,000		$ 31,600,000
Web-Hosting Services, November 2019-November 2022
Long-term Purchase Commitment [Line Items]
Purchase commitment				$ 30,000,000
Purchase commitment, term				3 years
Purchase commitment, incurred cost					3,900,000	$ 3,400,000	8,000,000	$ 6,600,000
Web-Hosting Services, November 2020
Long-term Purchase Commitment [Line Items]
Purchase commitment				$ 10,000,000
Web-Hosting Services, November 2021
Long-term Purchase Commitment [Line Items]
Purchase commitment				10,000,000
Web-Hosting Services, November 2022
Long-term Purchase Commitment [Line Items]
Purchase commitment				$ 10,000,000
Cloud Services, July 2022-July 2025
Long-term Purchase Commitment [Line Items]
Purchase commitment		$ 100,000,000
Purchase commitment, term		3 years
Purchase commitment, incurred cost					$ 1,300,000		$ 1,600,000

Stockholders' Equity (Details)

Stockholders' Equity (Details)	1 Months Ended		3 Months Ended		6 Months Ended		12 Months Ended
	Mar. 31, 2022 USD ($) shares	Dec. 31, 2021 USD ($)	Oct. 31, 2022 USD ($) vote $ / shares shares	Oct. 31, 2021 USD ($)	Oct. 31, 2022 USD ($) vote $ / shares shares	Oct. 31, 2021 USD ($)	Apr. 30, 2022 $ / shares shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Preferred stock, shares authorized (in shares)			200,000,000		200,000,000
Preferred stock, par value (in dollars per share) | $ / shares			$ 0.001		$ 0.001
Preferred stock, shares issued (in shares)			0		0
Preferred stock, shares outstanding (in shares)			0		0
Automatic conversion period, following the death or incapacity of Mr. Siebel					6 months
Automatic conversion period, following the date Mr. Siebel no longer providing services					6 months
Automatic conversion, anniversary period, if circumstances met					20 years
Net proceeds common stock exercised prior to vesting | $			$ 0	$ 0	$ 0	$ 0
Stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares subject to repurchase right (in shares)					247,155		373,790
Class A Common Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock, shares authorized (in shares)			1,000,000,000		1,000,000,000		1,000,000,000
Voting rights, number of votes for each share | vote			1		1
Common stock, par value (in dollars per share) | $ / shares			$ 0.001		$ 0.001		$ 0.001
Stock repurchase program, authorized amount (up to) | $		$ 100,000,000
Stock repurchase program, repurchase period		18 months
Repurchase and retirement of Class A common stock (in shares)	700,000
Repurchase and retirement of Class A common stock, value | $	$ 15,000,000
Stock repurchase program, shares repurchased (in shares)			0		0
Stock repurchase program, remaining amount available for repurchase | $			$ 85,000,000		$ 85,000,000
Class B Common Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock, shares authorized (in shares)			3,500,000		3,500,000		3,500,000
Voting rights, number of votes for each share | vote			50		50
Common stock, par value (in dollars per share) | $ / shares			$ 0.001		$ 0.001		$ 0.001

Stock-Based Compensation - Narr

Stock-Based Compensation - Narrative (Details)		3 Months Ended		6 Months Ended
	Nov. 27, 2020 USD ($) period shares	Oct. 31, 2022 USD ($)	Oct. 31, 2021 USD ($)	Oct. 31, 2022 USD ($) shares	Oct. 31, 2021 USD ($)	May 01, 2022	Apr. 30, 2022 USD ($)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock-based compensation expense		$ 56,013,000	$ 32,540,000	$ 112,643,000	$ 46,452,000
Accrued stock-settled bonus		20,224,000		20,224,000			$ 0
Stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation cost		131,000,000		$ 131,000,000
Unrecognized compensation cost, weighted-average recognition period				2 years 10 months 24 days
RSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation cost, weighted-average recognition period				3 years 9 months 18 days
Vesting period				5 years
Unrecognized stock-based compensation expense		414,400,000		$ 414,400,000
Granted, non-option (in shares) | shares				11,212,000
RSUs | Share-Based Payment Arrangement, Tranche One
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentages				20%
Vesting period				1 year
RSUs | Share-Based Payment Arrangement, Tranche Two
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentages				4%
2020 Incentive Plan | Stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expiration period (in years)				10 years
2020 Incentive Plan | Stock options | Share-Based Payment Arrangement, Tranche One
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentages				20%
Vesting period				1 year
2020 Incentive Plan | Stock options | Share-Based Payment Arrangement, Tranche Two
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentages				2%
Vesting period				4 years
2020 Employee Stock Purchase Plan | Employee Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized stock-based compensation expense		$ 6,100,000		$ 6,100,000
Percentage of employee earnings participation (up to)	15%
Initial offering period (in months)	24 months
Number of purchase periods | period	4
Purchase period (in months)	6 months
Total stock-based compensation expense				$ 300,000	$ 0
Common Class A and Common Class B | 2020 Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Automatic increase to shares reserved for future issuance, percent of total shares outstanding as of April 30, 2022						5%
Common Class A and Common Class B | 2020 Employee Stock Purchase Plan | Employee Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Automatic increase to shares reserved for future issuance, percent of total shares outstanding as of April 30, 2022						1%
Class A Common Stock | Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted, non-option (in shares) | shares				811,790
Class A Common Stock | 2020 Employee Stock Purchase Plan | Employee Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares reserved for future issuance (in shares) | shares	3,000,000
Shares purchased (in shares) | shares	2,500
Shares purchased	$ 25,000
Fair market value (as a percent)	85%

Stock-Based Compensation - Stoc

Stock-Based Compensation - Stock Option Activity (Details) $ / shares in Units, shares in Thousands, $ in Thousands	6 Months Ended	12 Months Ended
	Oct. 31, 2022 USD ($) $ / shares shares	Apr. 30, 2022 USD ($) $ / shares shares
Number of Stock Options Outstanding
Balance at beginning of period (in shares) | shares	36,338
Options granted (in shares) | shares	511
Options exercised (in shares) | shares	(577)
Options cancelled (in shares) | shares	(357)
Balance at end of period (in shares) | shares	35,915	36,338
Vested and exercisable at end of period (in shares) | shares	19,126
Vested and expected to vest at end of period (in shares) | shares	36,162
Weighted Average Exercise Price
Balance at beginning of period (in dollars per share) | $ / shares	$ 12.44
Options granted (in dollars per share) | $ / shares	13.74
Options exercised (in dollars per share) | $ / shares	16.34
Options cancelled (in dollars per share) | $ / shares	13.65
Balance at end of period (in dollars per share) | $ / shares	12.59	$ 12.44
Vested and exercisable at end of period (in dollars per share) | $ / shares	7.50
Vested and expected to vest at end of period (in dollars per share) | $ / shares	$ 12.59
Weighted Average Remaining Contractual Life (years)
Balance at beginning of period	6 years 11 months 4 days	7 years 4 months 2 days
Balance at end of period	6 years 11 months 4 days	7 years 4 months 2 days
Vested and exercisable at end of period	6 years 1 month 24 days
Vested and expected to vest at end of period	6 years 11 months 4 days
Aggregate Intrinsic Value
Balance at beginning of period | $	$ 18,676	$ 165,436
Balance at end of period | $	18,676	$ 165,436
Vested and exercisable at end of period | $	107,300
Vested and expected to vest at end of period | $	$ 18,804

Stock-Based Compensation - Valu

Stock-Based Compensation - Valuation Assumptions (Details)	6 Months Ended
	Oct. 31, 2022	Oct. 31, 2021
Valuation assumptions:
Expected dividend yield	0%	0%
Expected volatility	46.40%	43.90%
Expected term (years)	6 years 6 months	6 years 6 months
Risk-free interest rate	3.80%	1%
Employee Stock | 2020 Employee Stock Purchase Plan
Valuation assumptions:
Expected dividend yield	0%
Expected volatility, minimum	47.80%
Expected volatility, maximum	61.40%
Risk-free interest rate, minimum	4.30%
Risk-free interest rate, maximum	4.50%
Employee Stock | 2020 Employee Stock Purchase Plan | Minimum
Valuation assumptions:
Expected term (years)	4 months 24 days
Employee Stock | 2020 Employee Stock Purchase Plan | Maximum
Valuation assumptions:
Expected term (years)	1 year 10 months 24 days

Stock-Based Compensation - Rest

Stock-Based Compensation - Restricted Stock Unit Activity (Details) - RSUs shares in Thousands	6 Months Ended
	Oct. 31, 2022 $ / shares shares
Number of RSUs
Unvested Balance at beginning of period (in shares) | shares	12,109
RSUs granted (in shares) | shares	11,212
RSUs vested (in shares) | shares	(3,529)
RSUs forfeited (in shares) | shares	(2,221)
Unvested Balance at end of period (in shares) | shares	17,571
Weighted Average Grant Date Fair Value Per Share
Unvested Balance at beginning of period (in dollars per share) | $ / shares	$ 36.04
RSUs granted (in dollars per share) | $ / shares	17.77
RSUs vested (in dollars per share) | $ / shares	33.63
RSUs forfeited (in dollars per share) | $ / shares	34.22
Unvested Balance at end of period (in dollars per share) | $ / shares	$ 25.05

Stock-Based Compensation - St_2

Stock-Based Compensation - Stock-Based Compensation Expense (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Oct. 31, 2022	Oct. 31, 2021	Oct. 31, 2022	Oct. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock-based compensation expense	$ 56,013	$ 32,540	$ 112,643	$ 46,452
Cost of revenue | Subscription
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock-based compensation expense	5,486	2,364	9,758	3,185
Cost of revenue | Professional services
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock-based compensation expense	479	685	1,550	1,287
Sales and marketing
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock-based compensation expense	19,080	13,555	35,859	19,690
Research and development
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock-based compensation expense	23,905	10,256	49,122	13,014
General and administrative
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock-based compensation expense	$ 7,063	$ 5,680	$ 16,354	$ 9,276

Income Taxes (Details)

Income Taxes (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Oct. 31, 2022	Oct. 31, 2021	Oct. 31, 2022	Oct. 31, 2021
Income Tax Disclosure [Abstract]
Provision for income taxes	$ 163	$ 13	$ 342	$ 401

Net Loss Per Share Attributab_3

Net Loss Per Share Attributable to Common Stockholders - Computation of Basic and Diluted Net Loss Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Oct. 31, 2022	Oct. 31, 2021	Oct. 31, 2022	Oct. 31, 2021
Numerator
Net loss attributable to common stockholders	$ (68,850)	$ (56,739)	$ (140,721)	$ (94,198)
Denominator
Basic weighted-average common stock outstanding (in shares)	108,876	103,746	107,885	103,058
Diluted weighted-average common stock outstanding (in shares)	108,876	103,746	107,885	103,058
Basic and diluted net loss per share attributable to common stockholders
Basic net loss per common stock outstanding (in dollars per share)	$ (0.63)	$ (0.55)	$ (1.30)	$ (0.91)
Diluted net loss per common stock outstanding (in dollars per share)	$ (0.63)	$ (0.55)	$ (1.30)	$ (0.91)
Class A Common Stock
Denominator
Basic weighted-average common stock outstanding (in shares)	105,376	100,246	104,385	99,558
Diluted weighted-average common stock outstanding (in shares)	105,376	100,246	104,385	99,558
Basic and diluted net loss per share attributable to common stockholders
Basic net loss per common stock outstanding (in dollars per share)	$ (0.63)	$ (0.55)	$ (1.30)	$ (0.91)
Diluted net loss per common stock outstanding (in dollars per share)	$ (0.63)	$ (0.55)	$ (1.30)	$ (0.91)
Class B Common Stock
Denominator
Basic weighted-average common stock outstanding (in shares)	3,500	3,500	3,500	3,500
Diluted weighted-average common stock outstanding (in shares)	3,500	3,500	3,500	3,500
Basic and diluted net loss per share attributable to common stockholders
Basic net loss per common stock outstanding (in dollars per share)	$ (0.63)	$ (0.55)	$ (1.30)	$ (0.91)
Diluted net loss per common stock outstanding (in dollars per share)	$ (0.63)	$ (0.55)	$ (1.30)	$ (0.91)

Net Loss Per Share Attributab_4

Net Loss Per Share Attributable to Common Stockholders - Potential Shares Excluded From Computation of Diluted Net Loss Per Share (Details) - shares	6 Months Ended
	Oct. 31, 2022	Oct. 31, 2021
Stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially antidilutive shares excluded from computation of net loss per share (in shares)	36,162,330	37,824,606
RSUs
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially antidilutive shares excluded from computation of net loss per share (in shares)	17,570,508	6,041,895

Related Party Transactions (Det

Related Party Transactions (Details) - USD ($) $ in Thousands		1 Months Ended			3 Months Ended		6 Months Ended
		Oct. 31, 2021	Jun. 30, 2020	Jun. 30, 2019	Oct. 31, 2022	Oct. 31, 2021	Oct. 31, 2022	Oct. 31, 2021	Apr. 30, 2022
Related Party Transaction [Line Items]
Accounts receivable, net, inclusive of unbilled receivables from related party					$ 53,871		$ 53,871		$ 35,848
Deferred revenue, current	[1]				30,380		30,380		48,854
Sales and marketing expenses	[2]				44,936	$ 46,166	87,923	$ 82,988
Accounts payable, from related party					2,153		2,153		18,549
Commissions payable to a related party					2,448		2,448		2,510
Software Subscription Agreement | Baker Hughes Company
Related Party Transaction [Line Items]
Revenue commitment, fiscal year 2020			$ 46,700
Revenue commitment, fiscal year 2021			53,300
Revenue commitment, fiscal year 2022			75,000
Revenue commitment, fiscal year 2023		$ 85,000	125,000			85,000		85,000
Revenue commitment, fiscal year 2024		110,000	$ 150,000			110,000		110,000
Revenue commitment, fiscal year 2025		$ 125,000				125,000		125,000
Baker Hughes Company | Software Subscription Agreement
Related Party Transaction [Line Items]
Revenue commitment, term		6 years	5 years	3 years
Sales commissions, recognized as deferred costs		$ 16,000				$ 16,000		$ 16,000
Deferred costs, sales commissions, amortization period		5 years				5 years		5 years
Accounts receivable, net, inclusive of unbilled receivables from related party					53,900		53,900		35,800
Deferred revenue, current					400		400		100
Costs of subscription revenue					0	$ 100	0	$ 200
Sales and marketing expenses					3,500	100	7,000	200
Accounts payable, from related party					2,200		2,200		18,500
Deferred costs, sales commissions, prepaid expense and other current assets					4,900		4,900		4,900
Deferred costs, sales commissions, other assets, non-current					13,700		13,700		16,100
Deferred costs, sales commissions, amortization					1,200	$ 400	2,400	800
Sales commissions paid							16,000	$ 3,400
Commissions payable to a related party					2,400		2,400		2,500
Due to related parties, noncurrent					0		0		2,400
Baker Hughes Company | Software Subscription Agreement | Unbilled Revenues
Related Party Transaction [Line Items]
Accounts receivable, net, inclusive of unbilled receivables from related party					$ 53,000		$ 53,000		$ 16,500
[1]Including amounts from a related party of $387 and $132 as of October 31, 2022 and April 30, 2022, respectively.[2]Including related party sales and marketing expense of $3,531 and $131 for the three months ended October 31, 2022 and 2021, respectively, and $7,031 and $192 for the six months ended October 31, 2022 and 2021, respectively.

Related Party Transactions - Re

Related Party Transactions - Revenues Recognized For Related Party Transactions (Details) - Software Subscription Agreement - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Oct. 31, 2022	Oct. 31, 2021	Oct. 31, 2022	Oct. 31, 2021
Related Party Transaction [Line Items]
Related party revenue	$ 27,418	$ 20,553	$ 50,987	$ 36,702
Baker Hughes Company
Related Party Transaction [Line Items]
Related party revenue	19,259	15,936	35,718	28,218
Certain Customers In Oil And Gas Field
Related Party Transaction [Line Items]
Related party revenue	8,159	4,617	15,269	8,484
Subscription | Baker Hughes Company
Related Party Transaction [Line Items]
Related party revenue	19,238	10,012	35,568	20,220
Professional services | Baker Hughes Company
Related Party Transaction [Line Items]
Related party revenue	$ 21	$ 5,924	$ 150	$ 7,998

Related Party Transactions - _2

Related Party Transactions - Remaining Performance Obligations (Details) - USD ($) $ in Thousands	Oct. 31, 2022	Apr. 30, 2022	Oct. 31, 2021
Related Party Transaction [Line Items]
Deferred revenue	$ 30,600	$ 49,100
Total remaining performance obligations	417,300
Software Subscription Agreement | Baker Hughes Company
Related Party Transaction [Line Items]
Deferred revenue	387		$ 18,712
Commitments from non-cancellable contracts	184,550		282,325
Total remaining performance obligations	$ 184,937		$ 301,037